Gene Symbol | Gene ID | Gene Info |
---|---|---|
Vsx1
|
ENSMUSG00000033080.8 | visual system homeobox 1 |
Uncx
|
ENSMUSG00000029546.11 | UNC homeobox |
Prrx2
|
ENSMUSG00000039476.7 | paired related homeobox 2 |
Shox2
|
ENSMUSG00000027833.10 | short stature homeobox 2 |
Noto
|
ENSMUSG00000068302.7 | notochord homeobox |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_85399869_85400020 | Noto | 23942 | 0.109577 | -0.65 | 7.3e-08 | Click! |
chr6_85415954_85416113 | Noto | 7853 | 0.130456 | 0.40 | 2.7e-03 | Click! |
chr6_85410800_85410986 | Noto | 12993 | 0.123100 | -0.38 | 4.2e-03 | Click! |
chr6_85411130_85411286 | Noto | 12678 | 0.123456 | -0.13 | 3.6e-01 | Click! |
chr2_30836328_30836479 | Prrx2 | 1431 | 0.294405 | -0.34 | 1.0e-02 | Click! |
chr2_30836669_30836954 | Prrx2 | 1839 | 0.234564 | -0.34 | 1.2e-02 | Click! |
chr2_30834441_30834592 | Prrx2 | 456 | 0.724439 | 0.26 | 5.5e-02 | Click! |
chr2_30885923_30886074 | Prrx2 | 6679 | 0.136469 | -0.23 | 9.3e-02 | Click! |
chr2_30865207_30865358 | Prrx2 | 14037 | 0.123018 | 0.21 | 1.3e-01 | Click! |
chr3_66982400_66982685 | Shox2 | 771 | 0.505395 | -0.66 | 3.2e-08 | Click! |
chr3_66981878_66982104 | Shox2 | 220 | 0.795991 | -0.65 | 1.0e-07 | Click! |
chr3_66978681_66978832 | Shox2 | 55 | 0.969938 | -0.61 | 9.8e-07 | Click! |
chr3_66982134_66982300 | Shox2 | 446 | 0.656436 | -0.60 | 1.2e-06 | Click! |
chr3_66982726_66982877 | Shox2 | 1030 | 0.423631 | -0.58 | 4.4e-06 | Click! |
chr5_139568114_139568282 | Uncx | 24300 | 0.155323 | -0.82 | 1.2e-14 | Click! |
chr5_139581401_139581797 | Uncx | 37701 | 0.131718 | -0.79 | 1.2e-12 | Click! |
chr5_139568297_139568464 | Uncx | 24482 | 0.155040 | -0.77 | 7.1e-12 | Click! |
chr5_139558967_139559189 | Uncx | 15180 | 0.167529 | -0.76 | 1.2e-11 | Click! |
chr5_139536984_139537154 | Uncx | 6425 | 0.170287 | -0.76 | 2.3e-11 | Click! |
chr2_150688525_150689141 | Vsx1 | 527 | 0.675173 | -0.83 | 3.6e-15 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_109191268_109192295 | 329.09 |
Lmo1 |
LIM domain only 1 |
16574 |
0.17 |
chr17_47909349_47909983 | 298.21 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr6_138424907_138425582 | 294.62 |
Lmo3 |
LIM domain only 3 |
629 |
0.69 |
chr17_47914586_47915244 | 239.69 |
Gm15556 |
predicted gene 15556 |
7463 |
0.14 |
chr5_33542035_33542598 | 225.13 |
Fam53a |
family with sequence similarity 53, member A |
86596 |
0.05 |
chr6_138582721_138582913 | 215.54 |
Lmo3 |
LIM domain only 3 |
849 |
0.56 |
chr1_80408527_80409167 | 215.50 |
Gm6189 |
predicted gene 6189 |
23662 |
0.13 |
chr3_144174293_144174609 | 208.16 |
Lmo4 |
LIM domain only 4 |
20367 |
0.17 |
chr3_144198270_144199266 | 187.60 |
Gm43445 |
predicted gene 43445 |
494 |
0.79 |
chr5_112001700_112002600 | 172.12 |
Gm42488 |
predicted gene 42488 |
57915 |
0.13 |
chr6_146981244_146981874 | 164.56 |
Ppfibp1 |
PTPRF interacting protein, binding protein 1 (liprin beta 1) |
5076 |
0.15 |
chr16_72699156_72700074 | 160.49 |
Robo1 |
roundabout guidance receptor 1 |
36411 |
0.24 |
chr18_87921786_87922162 | 150.16 |
Gm24987 |
predicted gene, 24987 |
3590 |
0.34 |
chr10_127508848_127510720 | 146.53 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr8_108703603_108704102 | 143.18 |
Zfhx3 |
zinc finger homeobox 3 |
752 |
0.73 |
chr1_12409934_12410455 | 140.77 |
Mir6341 |
microRNA 6341 |
15792 |
0.23 |
chr6_98767823_98768513 | 120.06 |
Gm32308 |
predicted gene, 32308 |
10419 |
0.26 |
chr6_64274347_64275027 | 118.30 |
Gm25205 |
predicted gene, 25205 |
138961 |
0.05 |
chr18_3005171_3005609 | 116.97 |
Gm50072 |
predicted gene, 50072 |
10518 |
0.21 |
chr13_25392857_25393350 | 115.83 |
F830002E08Rik |
RIKEN cDNA F830002E08 gene |
37024 |
0.18 |
chr13_77548432_77549057 | 111.33 |
Gm9634 |
predicted gene 9634 |
5629 |
0.31 |
chr9_108338578_108339700 | 110.28 |
Gpx1 |
glutathione peroxidase 1 |
85 |
0.89 |
chr15_79690079_79691459 | 109.50 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr11_113014293_113014953 | 109.39 |
2610035D17Rik |
RIKEN cDNA 2610035D17 gene |
158454 |
0.04 |
chr7_29070679_29071390 | 107.17 |
Gm26604 |
predicted gene, 26604 |
569 |
0.5 |
chr3_79841487_79841829 | 106.39 |
Tmem144 |
transmembrane protein 144 |
71 |
0.97 |
chr3_157732464_157732921 | 105.11 |
Gm33466 |
predicted gene, 33466 |
6284 |
0.26 |
chr16_76319178_76320114 | 104.73 |
Nrip1 |
nuclear receptor interacting protein 1 |
4012 |
0.29 |
chr4_116720426_116721428 | 103.80 |
Tesk2 |
testis-specific kinase 2 |
21 |
0.96 |
chr4_83206835_83207691 | 102.21 |
Gm11185 |
predicted gene 11185 |
13275 |
0.19 |
chr7_4739300_4740219 | 97.66 |
Kmt5c |
lysine methyltransferase 5C |
356 |
0.63 |
chr18_35848127_35849279 | 97.42 |
Cxxc5 |
CXXC finger 5 |
5984 |
0.11 |
chr2_139724299_139724734 | 96.90 |
Ism1 |
isthmin 1, angiogenesis inhibitor |
46338 |
0.15 |
chr3_55075221_55075624 | 95.87 |
Gm43555 |
predicted gene 43555 |
17766 |
0.13 |
chr1_84960126_84960364 | 94.13 |
AC167036.1 |
novel protein |
1263 |
0.35 |
chr3_34504199_34504577 | 93.37 |
Gm29135 |
predicted gene 29135 |
22181 |
0.16 |
chr19_48545202_48545700 | 92.87 |
Sorcs3 |
sortilin-related VPS10 domain containing receptor 3 |
115491 |
0.07 |
chr3_108562098_108562631 | 92.63 |
Tmem167b |
transmembrane protein 167B |
102 |
0.92 |
chr6_9834968_9835442 | 88.86 |
Gm5110 |
predicted gene 5110 |
337649 |
0.01 |
chr19_4387351_4387502 | 88.23 |
Kdm2a |
lysine (K)-specific demethylase 2A |
9491 |
0.13 |
chr18_60605971_60606545 | 88.06 |
Synpo |
synaptopodin |
3847 |
0.19 |
chr5_60042722_60043044 | 87.56 |
Gm43393 |
predicted gene 43393 |
17000 |
0.17 |
chr6_91146547_91147358 | 86.96 |
Hdac11 |
histone deacetylase 11 |
9713 |
0.13 |
chr8_120293961_120294320 | 86.09 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
65684 |
0.09 |
chr14_76817069_76817629 | 85.70 |
Gm48968 |
predicted gene, 48968 |
15472 |
0.18 |
chr3_102203291_102203459 | 84.99 |
Vangl1 |
VANGL planar cell polarity 1 |
506 |
0.48 |
chr13_85126661_85127037 | 83.77 |
Gm4076 |
predicted gene 4076 |
665 |
0.69 |
chr5_139681780_139682442 | 82.46 |
Gm42424 |
predicted gene 42424 |
19536 |
0.16 |
chr3_29136074_29136608 | 82.42 |
Gm38029 |
predicted gene, 38029 |
38497 |
0.17 |
chr10_120387024_120387466 | 81.65 |
9230105E05Rik |
RIKEN cDNA 9230105E05 gene |
2278 |
0.28 |
chr4_141559124_141559929 | 80.44 |
B330016D10Rik |
RIKEN cDNA B330016D10 gene |
13337 |
0.12 |
chr11_60537440_60537820 | 80.06 |
Alkbh5 |
alkB homolog 5, RNA demethylase |
348 |
0.76 |
chr8_117089920_117090087 | 79.07 |
Bco1 |
beta-carotene oxygenase 1 |
5851 |
0.17 |
chr15_25498410_25498830 | 78.93 |
Gm48957 |
predicted gene, 48957 |
40131 |
0.14 |
chr9_61370339_61371660 | 77.98 |
Gm10655 |
predicted gene 10655 |
628 |
0.63 |
chr1_167802317_167803268 | 77.70 |
Lmx1a |
LIM homeobox transcription factor 1 alpha |
113235 |
0.07 |
chr12_41351050_41351632 | 77.60 |
Gm25497 |
predicted gene, 25497 |
2769 |
0.25 |
chr3_127930721_127931028 | 77.03 |
9830132P13Rik |
RIKEN cDNA 9830132P13 gene |
14702 |
0.14 |
chr1_86479174_86479713 | 76.56 |
Rpl30-ps6 |
ribosomal protein L30, pseudogene 6 |
5784 |
0.15 |
chr4_155213419_155213944 | 76.15 |
Ski |
ski sarcoma viral oncogene homolog (avian) |
8854 |
0.18 |
chr14_8286642_8286923 | 76.03 |
Fam107a |
family with sequence similarity 107, member A |
22995 |
0.16 |
chr14_48418768_48419083 | 75.93 |
Gm3534 |
predicted pseudogene 3534 |
10307 |
0.15 |
chr7_126263942_126264310 | 75.41 |
Sbk1 |
SH3-binding kinase 1 |
8493 |
0.12 |
chr2_105769867_105770156 | 73.28 |
Elp4 |
elongator acetyltransferase complex subunit 4 |
44311 |
0.13 |
chr2_84938621_84938923 | 72.85 |
Slc43a3 |
solute carrier family 43, member 3 |
1882 |
0.24 |
chr2_155604522_155604830 | 72.21 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
6536 |
0.08 |
chr7_125112792_125113319 | 71.24 |
Glud-ps |
glutamate dehydrogenase, pseudogene |
37704 |
0.17 |
chr18_56870554_56870904 | 71.07 |
Gm18087 |
predicted gene, 18087 |
45359 |
0.14 |
chr13_91890302_91890496 | 70.94 |
Ckmt2 |
creatine kinase, mitochondrial 2 |
13514 |
0.2 |
chr2_136148933_136149455 | 70.78 |
Gm14218 |
predicted gene 14218 |
12188 |
0.26 |
chr10_105423144_105423438 | 70.70 |
Gm48203 |
predicted gene, 48203 |
29005 |
0.15 |
chr7_109174643_109175577 | 70.70 |
Lmo1 |
LIM domain only 1 |
97 |
0.97 |
chrX_133653163_133653401 | 70.46 |
Pcdh19 |
protocadherin 19 |
31709 |
0.23 |
chr12_39885382_39885668 | 70.37 |
Gm4263 |
predicted gene 4263 |
10075 |
0.21 |
chr4_136773009_136773561 | 69.94 |
Ephb2 |
Eph receptor B2 |
62558 |
0.1 |
chr9_71163197_71163362 | 69.87 |
Aqp9 |
aquaporin 9 |
10 |
0.91 |
chr12_24889410_24890042 | 69.12 |
Mboat2 |
membrane bound O-acyltransferase domain containing 2 |
58095 |
0.09 |
chr11_3170338_3170795 | 67.83 |
Sfi1 |
Sfi1 homolog, spindle assembly associated (yeast) |
138 |
0.93 |
chr6_145276262_145276713 | 67.77 |
Rps25-ps1 |
ribosomal protein S25, pseudogene 1 |
10087 |
0.1 |
chr13_43480925_43481874 | 67.25 |
Ranbp9 |
RAN binding protein 9 |
117 |
0.95 |
chr12_29698179_29698919 | 67.17 |
C630031E19Rik |
RIKEN cDNA C630031E19 gene |
12104 |
0.29 |
chr3_119063671_119064008 | 67.02 |
Gm43410 |
predicted gene 43410 |
195595 |
0.03 |
chr13_43231981_43232458 | 66.57 |
Tbc1d7 |
TBC1 domain family, member 7 |
60718 |
0.11 |
chr19_24534375_24534662 | 66.21 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
21271 |
0.17 |
chr4_154121558_154121709 | 64.58 |
Trp73 |
transformation related protein 73 |
5028 |
0.13 |
chr8_12547924_12548627 | 64.33 |
Spaca7 |
sperm acrosome associated 7 |
24754 |
0.14 |
chr11_79961869_79962916 | 63.99 |
Utp6 |
UTP6 small subunit processome component |
2 |
0.97 |
chr6_42363179_42363495 | 63.75 |
2010310C07Rik |
RIKEN cDNA 2010310C07 gene |
7334 |
0.09 |
chr6_23280695_23281211 | 62.94 |
C130093G08Rik |
RIKEN cDNA C130093G08 gene |
29820 |
0.15 |
chr12_79674954_79675872 | 62.67 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
249320 |
0.02 |
chr16_33832938_33833368 | 62.26 |
Itgb5 |
integrin beta 5 |
3476 |
0.21 |
chr13_11836412_11836699 | 62.04 |
Ryr2 |
ryanodine receptor 2, cardiac |
6901 |
0.24 |
chr17_63171855_63172416 | 61.88 |
Gm24730 |
predicted gene, 24730 |
30603 |
0.21 |
chr4_80002679_80002838 | 61.77 |
Gm11407 |
predicted gene 11407 |
427 |
0.69 |
chr4_147433607_147433758 | 61.67 |
Gm13161 |
predicted gene 13161 |
9789 |
0.14 |
chr9_103288790_103289055 | 61.11 |
1300017J02Rik |
RIKEN cDNA 1300017J02 gene |
625 |
0.69 |
chr14_32164269_32164594 | 60.95 |
Ncoa4 |
nuclear receptor coactivator 4 |
1158 |
0.33 |
chr8_104602539_104603204 | 60.94 |
Cdh16 |
cadherin 16 |
10393 |
0.09 |
chr3_121291927_121292619 | 60.79 |
Alg14 |
asparagine-linked glycosylation 14 |
383 |
0.82 |
chr11_112976704_112977358 | 60.57 |
4933434M16Rik |
RIKEN cDNA 4933434M16 gene |
151852 |
0.04 |
chr14_26593397_26593744 | 60.36 |
Dennd6a |
DENN/MADD domain containing 6A |
11101 |
0.12 |
chr2_22587496_22588353 | 60.32 |
Gm13341 |
predicted gene 13341 |
38 |
0.95 |
chr5_145635834_145635985 | 60.15 |
Cyp3a63-ps |
cytochrome P450, family 3, subfamily a, member 63, pseudogene |
1916 |
0.29 |
chr14_33687535_33688054 | 59.95 |
Gm26228 |
predicted gene, 26228 |
43299 |
0.14 |
chr1_66862302_66862580 | 59.80 |
Acadl |
acyl-Coenzyme A dehydrogenase, long-chain |
836 |
0.42 |
chr2_35502647_35502805 | 59.72 |
Gm35202 |
predicted gene, 35202 |
805 |
0.53 |
chr4_32188849_32189105 | 59.50 |
Gm11929 |
predicted gene 11929 |
18171 |
0.19 |
chr18_78819335_78819486 | 59.11 |
Gm23895 |
predicted gene, 23895 |
171282 |
0.03 |
chr11_48855844_48857180 | 58.98 |
Gm16170 |
predicted gene 16170 |
3019 |
0.13 |
chr4_154122202_154122744 | 58.45 |
Trp73 |
transformation related protein 73 |
5868 |
0.12 |
chr5_111836465_111837021 | 58.13 |
Gm36535 |
predicted gene, 36535 |
43356 |
0.15 |
chr1_24612739_24612914 | 57.91 |
Gm10222 |
predicted gene 10222 |
126 |
0.59 |
chr12_72437630_72438246 | 57.87 |
Lrrc9 |
leucine rich repeat containing 9 |
3928 |
0.24 |
chr8_94898997_94899206 | 57.79 |
Ccdc102a |
coiled-coil domain containing 102A |
18420 |
0.1 |
chr12_83044271_83044926 | 57.72 |
Rgs6 |
regulator of G-protein signaling 6 |
2392 |
0.32 |
chr12_84590377_84590778 | 57.58 |
Abcd4 |
ATP-binding cassette, sub-family D (ALD), member 4 |
13475 |
0.15 |
chr10_13521965_13522177 | 57.51 |
Pex3 |
peroxisomal biogenesis factor 3 |
13890 |
0.17 |
chr14_52103963_52104507 | 57.40 |
Hnrnpc |
heterogeneous nuclear ribonucleoprotein C |
207 |
0.88 |
chr11_30648868_30649937 | 57.29 |
Acyp2 |
acylphosphatase 2, muscle type |
185 |
0.95 |
chr2_174291748_174291899 | 56.94 |
Gnasas1 |
GNAS antisense RNA 1 |
3566 |
0.16 |
chr2_160619427_160619728 | 56.55 |
Gm14221 |
predicted gene 14221 |
394 |
0.83 |
chr18_56871340_56871513 | 56.42 |
Gm18087 |
predicted gene, 18087 |
44662 |
0.14 |
chr3_6887007_6887616 | 55.78 |
Gm22074 |
predicted gene, 22074 |
89957 |
0.09 |
chr13_119232480_119232644 | 55.43 |
Gm44488 |
predicted gene, 44488 |
37042 |
0.17 |
chr8_117085925_117086139 | 55.41 |
Pkd1l2 |
polycystic kidney disease 1 like 2 |
3583 |
0.2 |
chr15_58592269_58592967 | 55.33 |
Fer1l6 |
fer-1-like 6 (C. elegans) |
45887 |
0.16 |
chr14_20116064_20116365 | 54.81 |
Saysd1 |
SAYSVFN motif domain containing 1 |
22320 |
0.14 |
chr14_9642536_9642687 | 54.75 |
Gm48371 |
predicted gene, 48371 |
173056 |
0.03 |
chr5_100125535_100125686 | 54.59 |
Tmem150c |
transmembrane protein 150C |
2814 |
0.23 |
chr6_118758618_118758929 | 54.36 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
799 |
0.74 |
chr2_170147589_170148059 | 54.25 |
Zfp217 |
zinc finger protein 217 |
279 |
0.95 |
chr2_153170625_153170776 | 54.12 |
Tm9sf4 |
transmembrane 9 superfamily protein member 4 |
9152 |
0.15 |
chr6_143260631_143261181 | 54.07 |
D6Ertd474e |
DNA segment, Chr 6, ERATO Doi 474, expressed |
15013 |
0.2 |
chr3_103799140_103799457 | 54.06 |
Gm15471 |
predicted gene 15471 |
3831 |
0.09 |
chr1_24615430_24615609 | 53.96 |
Gm28661 |
predicted gene 28661 |
46 |
0.86 |
chr13_16023381_16024064 | 53.61 |
B230303A05Rik |
RIKEN cDNA B230303A05 gene |
299 |
0.86 |
chr5_92404066_92404450 | 53.49 |
Art3 |
ADP-ribosyltransferase 3 |
2260 |
0.19 |
chr9_47279937_47280178 | 53.47 |
Gm31816 |
predicted gene, 31816 |
9314 |
0.26 |
chr3_152192027_152192235 | 53.44 |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
1714 |
0.25 |
chr3_96251008_96251159 | 53.43 |
Gm20627 |
predicted gene 20627 |
4386 |
0.04 |
chr10_21295422_21295685 | 53.29 |
Hbs1l |
Hbs1-like (S. cerevisiae) |
426 |
0.79 |
chr5_67400952_67401103 | 53.29 |
Bend4 |
BEN domain containing 4 |
26303 |
0.11 |
chr8_111312693_111312982 | 53.14 |
Mlkl |
mixed lineage kinase domain-like |
3282 |
0.18 |
chr9_44719978_44720480 | 52.99 |
Phldb1 |
pleckstrin homology like domain, family B, member 1 |
1158 |
0.26 |
chr1_168268952_168269254 | 52.99 |
Gm37524 |
predicted gene, 37524 |
68568 |
0.12 |
chr5_107251776_107252288 | 52.96 |
Gm42900 |
predicted gene 42900 |
4472 |
0.17 |
chr12_97061465_97061811 | 52.07 |
Gm47397 |
predicted gene, 47397 |
40826 |
0.21 |
chr10_118629771_118629922 | 51.99 |
Ifngas1 |
Ifng antisense RNA 1 |
73321 |
0.08 |
chr1_184629485_184629636 | 51.86 |
Gm37800 |
predicted gene, 37800 |
87 |
0.97 |
chr19_7605885_7606822 | 51.39 |
Lgals12 |
lectin, galactose binding, soluble 12 |
750 |
0.59 |
chr13_23533504_23534327 | 51.11 |
H2ac10 |
H2A clustered histone 10 |
9 |
0.78 |
chr4_132072343_132072494 | 51.06 |
Epb41 |
erythrocyte membrane protein band 4.1 |
321 |
0.8 |
chr7_143340680_143341191 | 50.99 |
Gm38095 |
predicted gene, 38095 |
3502 |
0.17 |
chr7_70331281_70331985 | 50.77 |
Gm29683 |
predicted gene, 29683 |
6189 |
0.14 |
chr9_106144221_106144589 | 50.71 |
D030055H07Rik |
RIKEN cDNA D030055H07 gene |
4282 |
0.1 |
chr1_184675628_184676155 | 50.38 |
Gm38358 |
predicted gene, 38358 |
19143 |
0.14 |
chr3_141952957_141953255 | 50.38 |
Bmpr1b |
bone morphogenetic protein receptor, type 1B |
21583 |
0.27 |
chr5_66337123_66338408 | 50.25 |
Apbb2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
83 |
0.96 |
chr17_36121540_36121726 | 49.71 |
Gm19684 |
predicted gene, 19684 |
45 |
0.63 |
chr7_126975552_126976438 | 49.69 |
Cdiptos |
CDIP transferase, opposite strand |
57 |
0.51 |
chr2_84793328_84793479 | 49.48 |
Ube2l6 |
ubiquitin-conjugating enzyme E2L 6 |
5425 |
0.11 |
chr5_139099227_139099378 | 49.45 |
Prkar1b |
protein kinase, cAMP dependent regulatory, type I beta |
13342 |
0.18 |
chr7_100590312_100590463 | 48.88 |
Mrpl48 |
mitochondrial ribosomal protein L48 |
1039 |
0.35 |
chr12_55052290_55052441 | 48.82 |
2700097O09Rik |
RIKEN cDNA 2700097O09 gene |
1736 |
0.23 |
chr1_78203643_78204022 | 48.49 |
Pax3 |
paired box 3 |
6698 |
0.23 |
chr16_95382153_95382455 | 48.41 |
Gm31641 |
predicted gene, 31641 |
26628 |
0.2 |
chr4_111635618_111636040 | 48.34 |
Agbl4 |
ATP/GTP binding protein-like 4 |
69104 |
0.11 |
chr11_99055574_99055970 | 47.27 |
Igfbp4 |
insulin-like growth factor binding protein 4 |
8461 |
0.12 |
chr13_21831513_21832288 | 47.22 |
Hist1h4n |
histone cluster 1, H4n |
296 |
0.63 |
chr16_25293836_25294037 | 47.22 |
Tprg |
transformation related protein 63 regulated |
7115 |
0.32 |
chr1_85307248_85307451 | 47.16 |
Gm16025 |
predicted gene 16025 |
19380 |
0.11 |
chr18_50133862_50134181 | 46.91 |
Cd63-ps |
CD63 antigen, pseudogene |
705 |
0.67 |
chr7_27481376_27481833 | 46.85 |
Sertad1 |
SERTA domain containing 1 |
5306 |
0.09 |
chr6_122590057_122590215 | 46.76 |
Apobec1 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 |
9991 |
0.1 |
chr1_77505970_77506663 | 46.49 |
Epha4 |
Eph receptor A4 |
8763 |
0.19 |
chr4_132075006_132075723 | 46.48 |
Epb41 |
erythrocyte membrane protein band 4.1 |
43 |
0.91 |
chr1_85580713_85581405 | 46.42 |
Sp110 |
Sp110 nuclear body protein |
3219 |
0.13 |
chr5_115235264_115235764 | 46.32 |
Pop5 |
processing of precursor 5, ribonuclease P/MRP family (S. cerevisiae) |
322 |
0.78 |
chr10_61413342_61413765 | 46.29 |
Nodal |
nodal |
4419 |
0.13 |
chr4_135817367_135817518 | 46.27 |
Myom3 |
myomesin family, member 3 |
16798 |
0.12 |
chr5_39438064_39438215 | 46.02 |
4930421C12Rik |
RIKEN cDNA 4930421C12 gene |
5435 |
0.2 |
chr14_65833206_65833566 | 46.00 |
Esco2 |
establishment of sister chromatid cohesion N-acetyltransferase 2 |
522 |
0.76 |
chr1_23282324_23282489 | 45.99 |
Gm27028 |
predicted gene, 27028 |
9131 |
0.12 |
chr17_21473484_21473684 | 45.97 |
Zfp53 |
zinc finger protein 53 |
15414 |
0.1 |
chr10_85127631_85128502 | 45.97 |
Mterf2 |
mitochondrial transcription termination factor 2 |
39 |
0.97 |
chr14_48445875_48446199 | 45.96 |
Tmem260 |
transmembrane protein 260 |
87 |
0.96 |
chr5_134932998_134933165 | 45.84 |
Mettl27 |
methyltransferase like 27 |
297 |
0.75 |
chr1_171263156_171263797 | 45.77 |
B4galt3 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 3 |
6852 |
0.07 |
chr5_4959496_4959832 | 45.48 |
Gm22897 |
predicted gene, 22897 |
25573 |
0.18 |
chr19_43767999_43768210 | 45.18 |
Cutc |
cutC copper transporter |
3231 |
0.18 |
chr3_96561958_96562124 | 45.09 |
Txnip |
thioredoxin interacting protein |
1987 |
0.13 |
chr14_76882933_76883168 | 44.94 |
Gm48969 |
predicted gene, 48969 |
21479 |
0.19 |
chr6_67161663_67162061 | 44.69 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
3062 |
0.22 |
chr17_79918069_79918346 | 44.47 |
Gm6552 |
predicted gene 6552 |
16365 |
0.16 |
chr15_76668038_76668213 | 44.45 |
Foxh1 |
forkhead box H1 |
1677 |
0.15 |
chr10_4433482_4433825 | 44.28 |
Armt1 |
acidic residue methyltransferase 1 |
928 |
0.39 |
chr8_91331323_91331874 | 44.15 |
Fto |
fat mass and obesity associated |
17984 |
0.13 |
chr5_149135169_149135434 | 44.10 |
Gm42787 |
predicted gene 42787 |
6717 |
0.1 |
chr4_35125058_35125826 | 44.07 |
Ifnk |
interferon kappa |
26614 |
0.16 |
chr19_53852714_53853452 | 43.95 |
Rbm20 |
RNA binding motif protein 20 |
9873 |
0.15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
36.3 | 108.8 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
34.9 | 104.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
32.6 | 130.2 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
21.7 | 65.2 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
18.6 | 55.7 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
16.5 | 82.4 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
16.4 | 32.8 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
15.6 | 78.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
14.8 | 44.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
14.5 | 43.6 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
14.0 | 42.1 | GO:0040031 | snRNA modification(GO:0040031) |
13.7 | 54.9 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
13.3 | 39.9 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
12.8 | 51.4 | GO:0010182 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
12.2 | 12.2 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
12.1 | 36.4 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
12.1 | 36.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
11.9 | 47.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
11.6 | 34.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
11.6 | 34.8 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
11.4 | 34.3 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
10.9 | 43.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
10.8 | 32.5 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
10.6 | 21.3 | GO:0051653 | spindle localization(GO:0051653) |
10.6 | 52.8 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
10.3 | 30.9 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
10.1 | 30.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
10.0 | 40.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
9.9 | 49.4 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
9.7 | 38.7 | GO:0006742 | NADP catabolic process(GO:0006742) |
9.6 | 19.2 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
9.3 | 28.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
9.3 | 65.1 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
9.3 | 27.8 | GO:0008050 | female courtship behavior(GO:0008050) |
9.2 | 9.2 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
9.1 | 36.3 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
9.1 | 18.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
9.1 | 27.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
8.7 | 8.7 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
8.6 | 25.7 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
8.5 | 50.8 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
8.4 | 58.7 | GO:0060613 | fat pad development(GO:0060613) |
8.4 | 25.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
8.3 | 16.6 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
8.2 | 32.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
8.2 | 40.8 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
8.1 | 24.4 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
8.1 | 16.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
8.0 | 32.2 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
8.0 | 8.0 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
8.0 | 39.8 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
8.0 | 31.8 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
7.9 | 23.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
7.9 | 39.6 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
7.9 | 23.7 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
7.8 | 15.7 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
7.8 | 23.5 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
7.8 | 15.6 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
7.7 | 30.7 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
7.6 | 22.8 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
7.6 | 7.6 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
7.6 | 30.3 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
7.5 | 37.6 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
7.5 | 15.0 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
7.5 | 22.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
7.4 | 386.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
7.4 | 14.8 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
7.4 | 36.9 | GO:0009249 | protein lipoylation(GO:0009249) |
7.1 | 21.4 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
7.1 | 85.1 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
7.1 | 49.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
7.1 | 21.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
7.0 | 14.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
7.0 | 28.0 | GO:0051031 | tRNA transport(GO:0051031) |
6.9 | 34.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
6.9 | 20.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
6.8 | 13.7 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
6.7 | 146.3 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
6.6 | 33.2 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
6.6 | 26.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
6.6 | 13.1 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
6.5 | 32.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
6.5 | 6.5 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
6.4 | 19.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
6.3 | 12.7 | GO:0018992 | germ-line sex determination(GO:0018992) |
6.3 | 31.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
6.3 | 12.5 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
6.2 | 18.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
6.2 | 18.6 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
6.2 | 6.2 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
6.0 | 24.2 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
6.0 | 6.0 | GO:0006573 | valine metabolic process(GO:0006573) |
6.0 | 90.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
5.9 | 23.8 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
5.9 | 23.7 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
5.9 | 23.6 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
5.9 | 17.7 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
5.9 | 47.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
5.9 | 11.8 | GO:0035087 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
5.8 | 17.5 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
5.8 | 5.8 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
5.8 | 17.3 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
5.8 | 17.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
5.8 | 5.8 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
5.7 | 17.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
5.6 | 16.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
5.6 | 5.6 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
5.6 | 11.2 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
5.6 | 16.8 | GO:1990928 | response to amino acid starvation(GO:1990928) |
5.6 | 11.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
5.5 | 16.6 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
5.5 | 16.6 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
5.5 | 5.5 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
5.5 | 16.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
5.5 | 71.5 | GO:0097286 | iron ion import(GO:0097286) |
5.5 | 21.9 | GO:0030916 | otic vesicle formation(GO:0030916) |
5.5 | 43.8 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
5.5 | 16.4 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
5.5 | 38.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
5.4 | 21.6 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
5.4 | 16.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
5.4 | 21.4 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
5.4 | 21.4 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
5.3 | 26.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
5.3 | 16.0 | GO:0036089 | cleavage furrow formation(GO:0036089) |
5.3 | 10.6 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
5.3 | 21.1 | GO:0019695 | choline metabolic process(GO:0019695) |
5.3 | 15.8 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
5.3 | 31.5 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
5.2 | 26.2 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
5.2 | 15.6 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
5.2 | 31.2 | GO:0015871 | choline transport(GO:0015871) |
5.2 | 15.5 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
5.2 | 15.5 | GO:1902990 | telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
5.2 | 10.3 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
5.2 | 20.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
5.1 | 5.1 | GO:0043584 | nose development(GO:0043584) |
5.1 | 40.9 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
5.0 | 10.0 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
5.0 | 75.3 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
5.0 | 5.0 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
4.9 | 14.8 | GO:0034436 | glycoprotein transport(GO:0034436) |
4.9 | 19.7 | GO:0007296 | vitellogenesis(GO:0007296) |
4.9 | 24.5 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
4.8 | 67.2 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
4.8 | 9.6 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
4.8 | 19.0 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
4.8 | 142.7 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
4.8 | 23.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
4.7 | 33.1 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
4.7 | 9.5 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
4.7 | 28.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
4.7 | 4.7 | GO:0035973 | aggrephagy(GO:0035973) |
4.7 | 32.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
4.7 | 28.1 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
4.7 | 23.3 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
4.6 | 18.5 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
4.6 | 32.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
4.6 | 4.6 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
4.6 | 13.7 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
4.6 | 18.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
4.6 | 13.7 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
4.6 | 27.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
4.5 | 13.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
4.5 | 18.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
4.5 | 13.6 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
4.5 | 31.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
4.5 | 26.9 | GO:0031017 | exocrine pancreas development(GO:0031017) |
4.5 | 31.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
4.4 | 53.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
4.4 | 4.4 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
4.4 | 8.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
4.4 | 21.8 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
4.4 | 17.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
4.3 | 13.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
4.3 | 8.7 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
4.3 | 8.7 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
4.3 | 21.6 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
4.3 | 17.3 | GO:0048539 | bone marrow development(GO:0048539) |
4.3 | 8.6 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
4.3 | 21.6 | GO:0009642 | response to light intensity(GO:0009642) |
4.3 | 17.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
4.3 | 17.2 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
4.3 | 8.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
4.2 | 55.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
4.2 | 8.5 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
4.2 | 8.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
4.2 | 46.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
4.2 | 12.7 | GO:0006059 | hexitol metabolic process(GO:0006059) |
4.2 | 16.9 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
4.2 | 16.8 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
4.2 | 8.4 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
4.2 | 20.8 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
4.1 | 29.0 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
4.1 | 12.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
4.1 | 12.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
4.1 | 12.2 | GO:0003383 | apical constriction(GO:0003383) |
4.1 | 36.5 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
4.0 | 16.1 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
4.0 | 8.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
4.0 | 16.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
4.0 | 16.1 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
4.0 | 67.8 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
4.0 | 4.0 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
4.0 | 35.8 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
4.0 | 11.9 | GO:0032264 | IMP salvage(GO:0032264) |
4.0 | 15.9 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
4.0 | 19.9 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
4.0 | 11.9 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
4.0 | 11.9 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
4.0 | 11.9 | GO:1903232 | melanosome assembly(GO:1903232) |
3.9 | 15.7 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
3.9 | 7.8 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
3.9 | 3.9 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
3.9 | 19.4 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
3.9 | 19.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
3.9 | 7.7 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
3.8 | 15.3 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
3.8 | 3.8 | GO:1901660 | calcium ion export(GO:1901660) |
3.8 | 22.9 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
3.8 | 41.9 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
3.8 | 15.2 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
3.8 | 18.9 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
3.8 | 48.8 | GO:0006855 | drug transmembrane transport(GO:0006855) |
3.7 | 15.0 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
3.7 | 11.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
3.7 | 18.6 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
3.7 | 18.6 | GO:0034227 | tRNA thio-modification(GO:0034227) |
3.7 | 7.4 | GO:0046104 | thymidine metabolic process(GO:0046104) |
3.7 | 7.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
3.7 | 11.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
3.7 | 11.1 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
3.7 | 18.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
3.7 | 7.3 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
3.7 | 11.0 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
3.7 | 18.3 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
3.7 | 47.5 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
3.6 | 47.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
3.6 | 29.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
3.6 | 29.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
3.6 | 21.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
3.6 | 21.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
3.6 | 46.9 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
3.6 | 21.6 | GO:0015671 | oxygen transport(GO:0015671) |
3.6 | 7.2 | GO:0030252 | growth hormone secretion(GO:0030252) |
3.6 | 3.6 | GO:0002432 | granuloma formation(GO:0002432) |
3.6 | 25.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
3.6 | 7.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
3.6 | 7.1 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
3.5 | 7.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
3.5 | 7.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
3.5 | 38.6 | GO:0042574 | retinal metabolic process(GO:0042574) |
3.5 | 17.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
3.5 | 10.5 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
3.5 | 3.5 | GO:0035909 | aorta morphogenesis(GO:0035909) |
3.5 | 10.5 | GO:0032898 | neurotrophin production(GO:0032898) |
3.5 | 24.4 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
3.5 | 7.0 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
3.5 | 10.4 | GO:0031639 | plasminogen activation(GO:0031639) |
3.5 | 13.9 | GO:0015886 | heme transport(GO:0015886) |
3.5 | 34.6 | GO:0030575 | nuclear body organization(GO:0030575) |
3.4 | 34.4 | GO:0019985 | translesion synthesis(GO:0019985) |
3.4 | 34.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
3.4 | 13.8 | GO:0070459 | prolactin secretion(GO:0070459) |
3.4 | 34.4 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
3.4 | 41.2 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
3.4 | 6.9 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
3.4 | 17.1 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
3.4 | 20.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
3.4 | 6.8 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
3.4 | 20.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
3.4 | 23.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
3.4 | 3.4 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
3.3 | 16.7 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
3.3 | 3.3 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
3.3 | 6.6 | GO:0060534 | trachea cartilage development(GO:0060534) |
3.3 | 13.3 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
3.3 | 46.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
3.3 | 9.9 | GO:1990034 | calcium ion export from cell(GO:1990034) |
3.3 | 16.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
3.3 | 6.6 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
3.3 | 9.9 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
3.3 | 108.6 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
3.3 | 6.6 | GO:0021569 | rhombomere 3 development(GO:0021569) |
3.3 | 3.3 | GO:0016078 | tRNA catabolic process(GO:0016078) |
3.3 | 6.5 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
3.3 | 6.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
3.2 | 22.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
3.2 | 19.4 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
3.2 | 9.7 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
3.2 | 16.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
3.2 | 9.6 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
3.2 | 19.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
3.2 | 6.3 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
3.2 | 9.5 | GO:0015888 | thiamine transport(GO:0015888) |
3.1 | 12.6 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
3.1 | 15.6 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
3.1 | 12.5 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
3.1 | 9.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
3.1 | 3.1 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
3.1 | 6.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
3.1 | 12.3 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
3.1 | 18.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
3.1 | 3.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
3.0 | 24.4 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
3.0 | 9.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
3.0 | 9.0 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
3.0 | 9.0 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
3.0 | 9.0 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
3.0 | 8.9 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
3.0 | 14.8 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
3.0 | 8.9 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
3.0 | 41.4 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
2.9 | 8.8 | GO:0060596 | mammary placode formation(GO:0060596) |
2.9 | 8.8 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
2.9 | 2.9 | GO:1902075 | cellular response to salt(GO:1902075) |
2.9 | 26.3 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
2.9 | 11.7 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
2.9 | 5.8 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
2.9 | 2.9 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
2.9 | 14.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
2.9 | 11.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
2.9 | 11.5 | GO:0018158 | protein oxidation(GO:0018158) |
2.9 | 5.8 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
2.9 | 8.7 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
2.9 | 31.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
2.9 | 8.6 | GO:0009629 | response to gravity(GO:0009629) |
2.9 | 2.9 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
2.9 | 8.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
2.9 | 2.9 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
2.9 | 28.5 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
2.8 | 14.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
2.8 | 8.5 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
2.8 | 8.5 | GO:0001880 | Mullerian duct regression(GO:0001880) |
2.8 | 34.1 | GO:1904353 | regulation of telomere capping(GO:1904353) positive regulation of telomere capping(GO:1904355) |
2.8 | 5.7 | GO:0044838 | cell quiescence(GO:0044838) |
2.8 | 19.8 | GO:0097264 | self proteolysis(GO:0097264) |
2.8 | 5.6 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
2.8 | 2.8 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
2.8 | 22.5 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
2.8 | 11.2 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
2.8 | 22.3 | GO:0032060 | bleb assembly(GO:0032060) |
2.8 | 13.9 | GO:0033572 | transferrin transport(GO:0033572) |
2.8 | 5.6 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
2.8 | 8.3 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
2.8 | 5.6 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
2.8 | 5.6 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
2.8 | 5.5 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
2.8 | 8.3 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
2.8 | 5.5 | GO:0000019 | regulation of mitotic recombination(GO:0000019) negative regulation of mitotic recombination(GO:0045950) |
2.7 | 16.4 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
2.7 | 109.6 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
2.7 | 2.7 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
2.7 | 8.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
2.7 | 19.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
2.7 | 5.5 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
2.7 | 46.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
2.7 | 8.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
2.7 | 8.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
2.7 | 5.4 | GO:0060594 | mammary gland specification(GO:0060594) |
2.7 | 5.4 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
2.7 | 5.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
2.7 | 5.4 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
2.7 | 18.9 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
2.7 | 10.8 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
2.7 | 2.7 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
2.7 | 8.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.7 | 5.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
2.7 | 2.7 | GO:0045606 | positive regulation of epidermal cell differentiation(GO:0045606) |
2.7 | 13.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
2.7 | 26.7 | GO:0006301 | postreplication repair(GO:0006301) |
2.7 | 13.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
2.7 | 2.7 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
2.6 | 7.9 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
2.6 | 5.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
2.6 | 5.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
2.6 | 2.6 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
2.6 | 2.6 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
2.6 | 15.7 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
2.6 | 15.7 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
2.6 | 7.8 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
2.6 | 2.6 | GO:0007619 | courtship behavior(GO:0007619) |
2.6 | 2.6 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
2.6 | 2.6 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
2.6 | 5.2 | GO:0002215 | defense response to nematode(GO:0002215) |
2.6 | 10.3 | GO:0051026 | chiasma assembly(GO:0051026) |
2.6 | 10.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
2.6 | 5.2 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
2.6 | 46.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
2.6 | 7.7 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
2.6 | 2.6 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
2.6 | 10.2 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
2.6 | 10.2 | GO:0051639 | actin filament network formation(GO:0051639) |
2.6 | 28.1 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
2.6 | 20.4 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
2.5 | 20.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
2.5 | 5.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
2.5 | 20.3 | GO:0043248 | proteasome assembly(GO:0043248) |
2.5 | 10.2 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
2.5 | 40.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
2.5 | 5.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
2.5 | 2.5 | GO:0010159 | specification of organ position(GO:0010159) |
2.5 | 12.6 | GO:0021670 | lateral ventricle development(GO:0021670) |
2.5 | 5.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
2.5 | 10.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
2.5 | 32.7 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
2.5 | 5.0 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
2.5 | 10.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
2.5 | 7.5 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
2.5 | 35.0 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
2.5 | 7.5 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) |
2.5 | 5.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
2.5 | 7.5 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
2.5 | 5.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
2.5 | 22.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
2.5 | 4.9 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
2.5 | 2.5 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
2.5 | 4.9 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
2.5 | 17.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
2.5 | 4.9 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
2.4 | 2.4 | GO:0032782 | bile acid secretion(GO:0032782) |
2.4 | 9.8 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
2.4 | 2.4 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
2.4 | 9.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
2.4 | 7.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
2.4 | 31.5 | GO:0006465 | signal peptide processing(GO:0006465) |
2.4 | 9.7 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
2.4 | 2.4 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
2.4 | 31.3 | GO:0006783 | heme biosynthetic process(GO:0006783) |
2.4 | 2.4 | GO:0003162 | atrioventricular node development(GO:0003162) |
2.4 | 7.2 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
2.4 | 141.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
2.4 | 12.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
2.4 | 19.1 | GO:0060539 | diaphragm development(GO:0060539) |
2.4 | 11.9 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
2.4 | 14.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
2.4 | 11.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
2.4 | 9.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
2.4 | 4.8 | GO:0009804 | coumarin metabolic process(GO:0009804) |
2.4 | 14.3 | GO:1904385 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
2.4 | 19.0 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
2.4 | 9.5 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
2.4 | 4.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
2.4 | 7.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
2.4 | 16.6 | GO:0009437 | carnitine metabolic process(GO:0009437) |
2.4 | 7.1 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
2.4 | 14.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
2.4 | 16.5 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
2.3 | 16.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
2.3 | 2.3 | GO:0033622 | integrin activation(GO:0033622) |
2.3 | 49.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
2.3 | 7.0 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
2.3 | 7.0 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
2.3 | 7.0 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
2.3 | 2.3 | GO:0042117 | monocyte activation(GO:0042117) |
2.3 | 25.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
2.3 | 9.3 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
2.3 | 2.3 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
2.3 | 14.0 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
2.3 | 7.0 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
2.3 | 34.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
2.3 | 30.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
2.3 | 7.0 | GO:0042045 | epithelial fluid transport(GO:0042045) |
2.3 | 7.0 | GO:0019086 | late viral transcription(GO:0019086) |
2.3 | 2.3 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
2.3 | 60.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
2.3 | 9.2 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
2.3 | 16.1 | GO:0015825 | L-serine transport(GO:0015825) |
2.3 | 9.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
2.3 | 50.7 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
2.3 | 9.2 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
2.3 | 101.0 | GO:0007569 | cell aging(GO:0007569) |
2.3 | 6.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
2.3 | 36.7 | GO:0060612 | adipose tissue development(GO:0060612) |
2.3 | 2.3 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
2.3 | 25.2 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
2.3 | 11.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
2.3 | 9.1 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
2.3 | 27.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
2.3 | 2.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
2.3 | 2.3 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
2.3 | 2.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
2.3 | 2.3 | GO:0090148 | membrane fission(GO:0090148) |
2.3 | 2.3 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
2.3 | 2.3 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.3 | 11.3 | GO:0060675 | branching involved in ureteric bud morphogenesis(GO:0001658) ureteric bud morphogenesis(GO:0060675) |
2.2 | 6.7 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
2.2 | 4.5 | GO:0010958 | regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
2.2 | 2.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
2.2 | 4.5 | GO:0002159 | desmosome assembly(GO:0002159) |
2.2 | 9.0 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
2.2 | 40.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
2.2 | 4.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
2.2 | 6.7 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
2.2 | 15.5 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
2.2 | 8.9 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
2.2 | 6.6 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
2.2 | 61.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
2.2 | 4.4 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
2.2 | 30.9 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
2.2 | 11.0 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
2.2 | 6.6 | GO:0032439 | endosome localization(GO:0032439) |
2.2 | 8.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
2.2 | 39.3 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
2.2 | 8.7 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
2.2 | 4.4 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
2.2 | 28.3 | GO:0043486 | histone exchange(GO:0043486) |
2.2 | 8.7 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
2.2 | 4.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
2.2 | 13.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
2.2 | 2.2 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
2.2 | 2.2 | GO:0046655 | folic acid metabolic process(GO:0046655) |
2.2 | 2.2 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
2.2 | 6.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
2.2 | 8.6 | GO:0072553 | terminal button organization(GO:0072553) |
2.2 | 15.1 | GO:0051382 | kinetochore assembly(GO:0051382) |
2.2 | 6.5 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
2.2 | 4.3 | GO:0006868 | glutamine transport(GO:0006868) |
2.1 | 34.4 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
2.1 | 2.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
2.1 | 2.1 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
2.1 | 4.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
2.1 | 10.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
2.1 | 6.4 | GO:0007525 | somatic muscle development(GO:0007525) |
2.1 | 6.4 | GO:0000087 | mitotic M phase(GO:0000087) |
2.1 | 6.4 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
2.1 | 6.4 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
2.1 | 4.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
2.1 | 4.2 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
2.1 | 10.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
2.1 | 2.1 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
2.1 | 12.7 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
2.1 | 4.2 | GO:0060789 | hair follicle placode formation(GO:0060789) |
2.1 | 6.3 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
2.1 | 4.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
2.1 | 8.4 | GO:1902893 | regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902893) positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
2.1 | 10.5 | GO:0007097 | nuclear migration(GO:0007097) |
2.1 | 6.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.1 | 6.3 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
2.1 | 10.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
2.1 | 77.6 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
2.1 | 8.4 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
2.1 | 18.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
2.1 | 2.1 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
2.1 | 6.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
2.1 | 6.3 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
2.1 | 2.1 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
2.1 | 10.4 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
2.1 | 14.6 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
2.1 | 8.3 | GO:0034333 | adherens junction assembly(GO:0034333) |
2.1 | 8.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
2.1 | 26.9 | GO:0006817 | phosphate ion transport(GO:0006817) |
2.1 | 2.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
2.1 | 14.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
2.1 | 2.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
2.1 | 6.2 | GO:0034508 | centromere complex assembly(GO:0034508) |
2.1 | 24.7 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
2.1 | 16.5 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
2.1 | 35.0 | GO:0071514 | genetic imprinting(GO:0071514) |
2.0 | 40.9 | GO:0000266 | mitochondrial fission(GO:0000266) |
2.0 | 8.2 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
2.0 | 2.0 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
2.0 | 4.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
2.0 | 2.0 | GO:0016556 | mRNA modification(GO:0016556) |
2.0 | 4.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
2.0 | 16.3 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
2.0 | 12.2 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
2.0 | 6.1 | GO:0016264 | gap junction assembly(GO:0016264) |
2.0 | 14.2 | GO:0046415 | urate metabolic process(GO:0046415) |
2.0 | 6.1 | GO:0021564 | vagus nerve development(GO:0021564) |
2.0 | 2.0 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
2.0 | 6.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
2.0 | 6.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
2.0 | 12.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
2.0 | 2.0 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
2.0 | 14.0 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
2.0 | 8.0 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
2.0 | 20.0 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
2.0 | 2.0 | GO:0071435 | potassium ion export(GO:0071435) |
2.0 | 6.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
2.0 | 7.9 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
2.0 | 5.9 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
2.0 | 11.9 | GO:0051013 | microtubule severing(GO:0051013) |
2.0 | 2.0 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
2.0 | 2.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
2.0 | 9.9 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
2.0 | 2.0 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
2.0 | 17.7 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
1.9 | 3.9 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.9 | 21.4 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
1.9 | 7.8 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.9 | 5.8 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
1.9 | 42.6 | GO:0030032 | lamellipodium assembly(GO:0030032) |
1.9 | 3.9 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
1.9 | 7.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.9 | 11.5 | GO:1902116 | negative regulation of organelle assembly(GO:1902116) |
1.9 | 3.8 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
1.9 | 51.7 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
1.9 | 9.6 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
1.9 | 5.7 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.9 | 7.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.9 | 3.8 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
1.9 | 1.9 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) |
1.9 | 24.7 | GO:0002063 | chondrocyte development(GO:0002063) |
1.9 | 3.8 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.9 | 3.8 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
1.9 | 15.2 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
1.9 | 3.8 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.9 | 3.8 | GO:0002445 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
1.9 | 3.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.9 | 11.3 | GO:0006477 | protein sulfation(GO:0006477) |
1.9 | 1.9 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
1.9 | 5.6 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
1.9 | 1.9 | GO:0090184 | positive regulation of kidney development(GO:0090184) |
1.9 | 15.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
1.9 | 3.7 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.9 | 9.3 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
1.9 | 13.0 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
1.9 | 9.3 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
1.9 | 16.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
1.9 | 14.8 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
1.9 | 1.9 | GO:0061511 | centriole elongation(GO:0061511) |
1.8 | 5.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
1.8 | 7.4 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
1.8 | 3.7 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
1.8 | 5.5 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
1.8 | 27.4 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
1.8 | 9.1 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
1.8 | 3.6 | GO:0070989 | oxidative demethylation(GO:0070989) |
1.8 | 12.7 | GO:0070269 | pyroptosis(GO:0070269) |
1.8 | 3.6 | GO:0072672 | neutrophil extravasation(GO:0072672) |
1.8 | 5.4 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
1.8 | 3.6 | GO:0002254 | kinin cascade(GO:0002254) |
1.8 | 3.6 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
1.8 | 1.8 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
1.8 | 3.6 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) positive regulation of sequestering of triglyceride(GO:0010890) |
1.8 | 5.4 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
1.8 | 5.4 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
1.8 | 7.2 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.8 | 7.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.8 | 12.6 | GO:0046686 | response to cadmium ion(GO:0046686) |
1.8 | 3.6 | GO:0060438 | trachea development(GO:0060438) |
1.8 | 5.4 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
1.8 | 10.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
1.8 | 3.6 | GO:0014910 | regulation of smooth muscle cell migration(GO:0014910) |
1.8 | 5.4 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
1.8 | 26.8 | GO:0070207 | protein homotrimerization(GO:0070207) |
1.8 | 5.4 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
1.8 | 8.9 | GO:0006527 | arginine catabolic process(GO:0006527) |
1.8 | 8.9 | GO:1902402 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
1.8 | 1.8 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
1.8 | 5.3 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
1.8 | 8.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.8 | 3.6 | GO:0032202 | telomere assembly(GO:0032202) |
1.8 | 10.7 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
1.8 | 7.1 | GO:0043967 | histone H4 acetylation(GO:0043967) |
1.8 | 5.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
1.8 | 8.8 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
1.8 | 3.5 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
1.8 | 14.1 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) negative regulation of blood vessel morphogenesis(GO:2000181) |
1.8 | 7.0 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
1.8 | 7.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
1.8 | 19.3 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
1.8 | 7.0 | GO:0070475 | rRNA base methylation(GO:0070475) |
1.8 | 5.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
1.8 | 8.8 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
1.8 | 1.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.7 | 29.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
1.7 | 1.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
1.7 | 7.0 | GO:0044557 | relaxation of smooth muscle(GO:0044557) relaxation of vascular smooth muscle(GO:0060087) |
1.7 | 1.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.7 | 3.5 | GO:0051775 | response to redox state(GO:0051775) |
1.7 | 60.7 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
1.7 | 26.0 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
1.7 | 24.2 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
1.7 | 5.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
1.7 | 22.5 | GO:0051452 | intracellular pH reduction(GO:0051452) |
1.7 | 10.4 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
1.7 | 3.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
1.7 | 48.1 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
1.7 | 6.9 | GO:0002786 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
1.7 | 8.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
1.7 | 1.7 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
1.7 | 5.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.7 | 77.1 | GO:0051225 | spindle assembly(GO:0051225) |
1.7 | 8.6 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
1.7 | 3.4 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
1.7 | 10.2 | GO:0044819 | mitotic G1/S transition checkpoint(GO:0044819) |
1.7 | 46.0 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
1.7 | 15.3 | GO:0030449 | regulation of complement activation(GO:0030449) |
1.7 | 1.7 | GO:0048565 | digestive tract development(GO:0048565) |
1.7 | 11.8 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
1.7 | 3.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
1.7 | 3.4 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
1.7 | 1.7 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
1.7 | 1.7 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
1.7 | 8.4 | GO:0001842 | neural fold formation(GO:0001842) |
1.7 | 20.2 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
1.7 | 6.7 | GO:0007144 | female meiosis I(GO:0007144) |
1.7 | 1.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
1.7 | 1.7 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
1.7 | 5.0 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
1.7 | 3.3 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
1.7 | 5.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
1.7 | 5.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.7 | 6.7 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
1.7 | 3.3 | GO:0061083 | regulation of protein refolding(GO:0061083) |
1.7 | 3.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
1.7 | 1.7 | GO:0060502 | epithelial cell proliferation involved in lung morphogenesis(GO:0060502) |
1.7 | 8.3 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.7 | 3.3 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) |
1.7 | 59.6 | GO:0003341 | cilium movement(GO:0003341) |
1.6 | 3.3 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
1.6 | 4.9 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
1.6 | 4.9 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
1.6 | 3.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
1.6 | 1.6 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
1.6 | 1.6 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
1.6 | 1.6 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
1.6 | 6.6 | GO:0061008 | hepaticobiliary system development(GO:0061008) |
1.6 | 6.5 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
1.6 | 8.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.6 | 26.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
1.6 | 16.3 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
1.6 | 3.3 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
1.6 | 6.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.6 | 3.3 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
1.6 | 13.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
1.6 | 4.9 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
1.6 | 29.2 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
1.6 | 1.6 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.6 | 3.2 | GO:0043307 | eosinophil activation(GO:0043307) |
1.6 | 34.0 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
1.6 | 4.9 | GO:0048747 | muscle fiber development(GO:0048747) |
1.6 | 3.2 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.6 | 4.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.6 | 3.2 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
1.6 | 4.8 | GO:0032532 | regulation of microvillus length(GO:0032532) |
1.6 | 1.6 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
1.6 | 1.6 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
1.6 | 3.2 | GO:0022615 | protein to membrane docking(GO:0022615) |
1.6 | 3.2 | GO:0034694 | response to prostaglandin(GO:0034694) |
1.6 | 4.8 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.6 | 4.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
1.6 | 1.6 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
1.6 | 15.9 | GO:0001952 | regulation of cell-matrix adhesion(GO:0001952) |
1.6 | 1.6 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
1.6 | 1.6 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
1.6 | 3.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.6 | 1.6 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
1.6 | 7.9 | GO:0046085 | adenosine metabolic process(GO:0046085) |
1.6 | 4.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
1.6 | 1.6 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
1.6 | 3.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
1.6 | 3.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
1.6 | 34.6 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
1.6 | 3.1 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.6 | 3.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
1.6 | 12.6 | GO:0034063 | stress granule assembly(GO:0034063) |
1.6 | 1.6 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.6 | 6.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.6 | 3.1 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
1.6 | 1.6 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
1.6 | 3.1 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
1.6 | 17.2 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
1.6 | 9.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
1.6 | 35.7 | GO:0051298 | centrosome duplication(GO:0051298) |
1.5 | 3.1 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
1.5 | 15.4 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
1.5 | 1.5 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
1.5 | 9.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
1.5 | 9.2 | GO:0048368 | lateral mesoderm development(GO:0048368) |
1.5 | 4.6 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
1.5 | 3.1 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
1.5 | 10.7 | GO:0001771 | immunological synapse formation(GO:0001771) |
1.5 | 12.2 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
1.5 | 3.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
1.5 | 4.6 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.5 | 12.2 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
1.5 | 1.5 | GO:0014831 | gastro-intestinal system smooth muscle contraction(GO:0014831) |
1.5 | 1.5 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
1.5 | 3.0 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
1.5 | 10.6 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
1.5 | 9.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
1.5 | 1.5 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
1.5 | 24.1 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
1.5 | 3.0 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
1.5 | 9.0 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
1.5 | 1.5 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
1.5 | 45.0 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
1.5 | 3.0 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
1.5 | 29.9 | GO:0006101 | tricarboxylic acid cycle(GO:0006099) citrate metabolic process(GO:0006101) |
1.5 | 4.5 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
1.5 | 1.5 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
1.5 | 16.4 | GO:0009303 | rRNA transcription(GO:0009303) |
1.5 | 49.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
1.5 | 10.4 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
1.5 | 4.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
1.5 | 1.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.5 | 5.9 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
1.5 | 3.0 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.5 | 7.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.5 | 7.4 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
1.5 | 1.5 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.5 | 3.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
1.5 | 8.9 | GO:0070307 | lens fiber cell development(GO:0070307) |
1.5 | 19.2 | GO:0014823 | response to activity(GO:0014823) |
1.5 | 14.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
1.5 | 8.8 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
1.5 | 5.9 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
1.5 | 2.9 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
1.5 | 1.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.5 | 7.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
1.5 | 5.8 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
1.5 | 5.8 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
1.5 | 1.5 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
1.5 | 5.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.5 | 4.4 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
1.5 | 7.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.5 | 18.9 | GO:0048266 | behavioral response to pain(GO:0048266) |
1.5 | 1.5 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
1.4 | 1.4 | GO:1900368 | regulation of RNA interference(GO:1900368) |
1.4 | 4.3 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
1.4 | 50.3 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
1.4 | 4.3 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
1.4 | 5.7 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
1.4 | 35.9 | GO:0006953 | acute-phase response(GO:0006953) |
1.4 | 1.4 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
1.4 | 10.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
1.4 | 5.7 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
1.4 | 2.9 | GO:0071865 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
1.4 | 2.9 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
1.4 | 2.9 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
1.4 | 2.9 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
1.4 | 1.4 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
1.4 | 2.9 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
1.4 | 14.2 | GO:0006828 | manganese ion transport(GO:0006828) |
1.4 | 1.4 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
1.4 | 1.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.4 | 2.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.4 | 1.4 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
1.4 | 5.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.4 | 12.8 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
1.4 | 1.4 | GO:0072053 | renal inner medulla development(GO:0072053) |
1.4 | 2.8 | GO:0015705 | iodide transport(GO:0015705) |
1.4 | 1.4 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
1.4 | 4.2 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
1.4 | 73.4 | GO:0050821 | protein stabilization(GO:0050821) |
1.4 | 4.2 | GO:0006083 | acetate metabolic process(GO:0006083) |
1.4 | 7.1 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
1.4 | 29.6 | GO:0048240 | sperm capacitation(GO:0048240) |
1.4 | 2.8 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
1.4 | 9.8 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
1.4 | 11.2 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
1.4 | 11.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
1.4 | 8.4 | GO:0098727 | maintenance of cell number(GO:0098727) |
1.4 | 16.8 | GO:0048821 | erythrocyte development(GO:0048821) |
1.4 | 8.4 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
1.4 | 20.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
1.4 | 4.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.4 | 12.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
1.4 | 1.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.4 | 1.4 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.4 | 2.8 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
1.4 | 4.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
1.4 | 1.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.4 | 2.8 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
1.4 | 20.8 | GO:0007052 | mitotic spindle organization(GO:0007052) |
1.4 | 4.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.4 | 6.9 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
1.4 | 1.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.4 | 2.8 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
1.4 | 2.8 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
1.4 | 34.5 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
1.4 | 19.3 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
1.4 | 2.7 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
1.4 | 1.4 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
1.4 | 6.8 | GO:0010092 | specification of organ identity(GO:0010092) |
1.4 | 1.4 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
1.4 | 5.5 | GO:0006907 | pinocytosis(GO:0006907) |
1.4 | 1.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
1.4 | 62.7 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
1.4 | 5.4 | GO:0098930 | axonal transport(GO:0098930) |
1.4 | 1.4 | GO:1903320 | regulation of protein modification by small protein conjugation or removal(GO:1903320) |
1.4 | 4.1 | GO:0006057 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
1.4 | 1.4 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
1.4 | 10.9 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
1.4 | 5.4 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
1.4 | 5.4 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
1.4 | 63.5 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
1.3 | 1.3 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
1.3 | 4.0 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
1.3 | 1.3 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
1.3 | 2.7 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
1.3 | 29.5 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
1.3 | 17.4 | GO:0030488 | tRNA methylation(GO:0030488) |
1.3 | 2.7 | GO:0009838 | abscission(GO:0009838) |
1.3 | 1.3 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
1.3 | 15.9 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
1.3 | 4.0 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.3 | 4.0 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
1.3 | 6.6 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
1.3 | 22.4 | GO:1901998 | toxin transport(GO:1901998) |
1.3 | 6.6 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
1.3 | 5.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
1.3 | 1.3 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
1.3 | 9.2 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
1.3 | 11.8 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
1.3 | 1.3 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
1.3 | 2.6 | GO:0060290 | transdifferentiation(GO:0060290) |
1.3 | 5.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.3 | 6.5 | GO:0046836 | glycolipid transport(GO:0046836) |
1.3 | 1.3 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
1.3 | 3.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.3 | 66.2 | GO:0006457 | protein folding(GO:0006457) |
1.3 | 2.6 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
1.3 | 6.5 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
1.3 | 2.6 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
1.3 | 2.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.3 | 5.2 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
1.3 | 3.9 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
1.3 | 3.9 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
1.3 | 1.3 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
1.3 | 1.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
1.3 | 5.1 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
1.3 | 3.8 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.3 | 1.3 | GO:2000407 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
1.3 | 15.4 | GO:0045116 | protein neddylation(GO:0045116) |
1.3 | 3.8 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
1.3 | 39.5 | GO:0001824 | blastocyst development(GO:0001824) |
1.3 | 15.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
1.3 | 1.3 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.3 | 2.5 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
1.3 | 8.9 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.3 | 6.3 | GO:0043084 | penile erection(GO:0043084) |
1.3 | 39.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
1.3 | 1.3 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
1.3 | 6.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
1.3 | 5.0 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
1.3 | 1.3 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
1.3 | 8.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.3 | 13.8 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
1.3 | 3.8 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
1.2 | 5.0 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
1.2 | 2.5 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
1.2 | 2.5 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
1.2 | 13.7 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
1.2 | 7.5 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
1.2 | 6.2 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
1.2 | 4.9 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
1.2 | 2.5 | GO:0009299 | mRNA transcription(GO:0009299) |
1.2 | 7.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.2 | 2.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.2 | 2.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.2 | 2.5 | GO:1904377 | positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
1.2 | 2.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.2 | 2.5 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
1.2 | 2.5 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
1.2 | 2.4 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) lamellipodium organization(GO:0097581) |
1.2 | 2.4 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
1.2 | 8.5 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
1.2 | 32.8 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
1.2 | 6.1 | GO:0030913 | paranodal junction assembly(GO:0030913) |
1.2 | 7.3 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
1.2 | 3.6 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
1.2 | 1.2 | GO:0051154 | negative regulation of striated muscle cell differentiation(GO:0051154) |
1.2 | 1.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.2 | 6.0 | GO:0015846 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
1.2 | 3.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.2 | 6.0 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
1.2 | 1.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.2 | 3.6 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
1.2 | 4.8 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
1.2 | 8.4 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
1.2 | 1.2 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
1.2 | 1.2 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
1.2 | 4.8 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
1.2 | 4.8 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
1.2 | 13.1 | GO:0002347 | response to tumor cell(GO:0002347) |
1.2 | 3.6 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
1.2 | 8.3 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
1.2 | 1.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
1.2 | 61.4 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
1.2 | 3.5 | GO:0060056 | mammary gland involution(GO:0060056) |
1.2 | 1.2 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
1.2 | 8.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
1.2 | 17.7 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
1.2 | 1.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
1.2 | 8.2 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
1.2 | 7.0 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
1.2 | 1.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.2 | 10.5 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
1.2 | 12.8 | GO:0006706 | steroid catabolic process(GO:0006706) |
1.2 | 1.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
1.2 | 4.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.2 | 9.3 | GO:0042407 | cristae formation(GO:0042407) |
1.2 | 2.3 | GO:0043489 | RNA stabilization(GO:0043489) |
1.2 | 4.6 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
1.2 | 6.9 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
1.2 | 3.5 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
1.2 | 5.8 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
1.2 | 4.6 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
1.2 | 3.5 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
1.2 | 30.0 | GO:0060976 | coronary vasculature development(GO:0060976) |
1.1 | 1.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
1.1 | 4.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
1.1 | 3.4 | GO:0002176 | male germ cell proliferation(GO:0002176) |
1.1 | 1.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.1 | 3.4 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
1.1 | 2.3 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
1.1 | 2.3 | GO:1901032 | negative regulation of response to reactive oxygen species(GO:1901032) |
1.1 | 1.1 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
1.1 | 4.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
1.1 | 1.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.1 | 4.5 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
1.1 | 189.7 | GO:0008380 | RNA splicing(GO:0008380) |
1.1 | 2.3 | GO:0019081 | viral translation(GO:0019081) |
1.1 | 79.0 | GO:0000209 | protein polyubiquitination(GO:0000209) |
1.1 | 12.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.1 | 2.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
1.1 | 5.6 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
1.1 | 2.2 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
1.1 | 4.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
1.1 | 2.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.1 | 1.1 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
1.1 | 7.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.1 | 2.2 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
1.1 | 2.2 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
1.1 | 2.2 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
1.1 | 3.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
1.1 | 2.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.1 | 5.6 | GO:0060009 | Sertoli cell development(GO:0060009) |
1.1 | 2.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
1.1 | 1.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
1.1 | 14.3 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
1.1 | 1.1 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
1.1 | 1.1 | GO:1904970 | brush border assembly(GO:1904970) |
1.1 | 1.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
1.1 | 2.2 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
1.1 | 4.4 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
1.1 | 6.6 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
1.1 | 7.7 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
1.1 | 3.3 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
1.1 | 1.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
1.1 | 10.9 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
1.1 | 17.4 | GO:0070527 | platelet aggregation(GO:0070527) |
1.1 | 2.2 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
1.1 | 72.5 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
1.1 | 3.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
1.1 | 1.1 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
1.1 | 2.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.1 | 7.5 | GO:0019321 | pentose metabolic process(GO:0019321) |
1.1 | 7.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
1.1 | 1.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
1.1 | 37.5 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
1.1 | 1.1 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
1.1 | 5.3 | GO:0022618 | ribonucleoprotein complex assembly(GO:0022618) |
1.1 | 1.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
1.1 | 2.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
1.1 | 1.1 | GO:0060677 | ureteric bud elongation(GO:0060677) |
1.1 | 21.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
1.1 | 4.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
1.1 | 4.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
1.1 | 10.6 | GO:0043409 | negative regulation of MAPK cascade(GO:0043409) |
1.1 | 2.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
1.1 | 4.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
1.1 | 17.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
1.1 | 7.4 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
1.0 | 3.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
1.0 | 3.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
1.0 | 16.8 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
1.0 | 3.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.0 | 2.1 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.0 | 2.1 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
1.0 | 3.1 | GO:1903311 | regulation of mRNA metabolic process(GO:1903311) |
1.0 | 10.4 | GO:0001947 | heart looping(GO:0001947) |
1.0 | 1.0 | GO:1903543 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
1.0 | 7.2 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
1.0 | 1.0 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
1.0 | 2.1 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
1.0 | 3.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.0 | 1.0 | GO:0051657 | maintenance of organelle location(GO:0051657) |
1.0 | 3.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.0 | 1.0 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
1.0 | 1.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.0 | 6.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
1.0 | 6.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
1.0 | 2.0 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
1.0 | 63.3 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
1.0 | 52.0 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
1.0 | 3.1 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
1.0 | 8.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
1.0 | 2.0 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
1.0 | 1.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
1.0 | 29.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
1.0 | 1.0 | GO:0035050 | embryonic heart tube development(GO:0035050) |
1.0 | 4.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
1.0 | 2.0 | GO:0033762 | response to glucagon(GO:0033762) |
1.0 | 3.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.0 | 7.1 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
1.0 | 3.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.0 | 3.0 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
1.0 | 2.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
1.0 | 1.0 | GO:0010574 | regulation of vascular endothelial growth factor production(GO:0010574) |
1.0 | 6.0 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
1.0 | 1.0 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
1.0 | 14.0 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
1.0 | 1.0 | GO:0019530 | taurine metabolic process(GO:0019530) |
1.0 | 1.0 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
1.0 | 27.9 | GO:0006475 | internal protein amino acid acetylation(GO:0006475) |
1.0 | 1.0 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
1.0 | 4.0 | GO:0032642 | regulation of chemokine production(GO:0032642) |
1.0 | 15.9 | GO:1904029 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
1.0 | 9.9 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
1.0 | 1.0 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
1.0 | 9.9 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
1.0 | 1.0 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
1.0 | 5.9 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
1.0 | 4.0 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
1.0 | 2.0 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.0 | 13.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
1.0 | 12.8 | GO:0016180 | snRNA processing(GO:0016180) |
1.0 | 1.0 | GO:0010324 | membrane invagination(GO:0010324) |
1.0 | 4.9 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
1.0 | 2.9 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.0 | 2.9 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
1.0 | 1.0 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
1.0 | 114.1 | GO:0016567 | protein ubiquitination(GO:0016567) |
1.0 | 2.9 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
1.0 | 14.6 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
1.0 | 3.9 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
1.0 | 9.7 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
1.0 | 1.9 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.0 | 10.7 | GO:0097484 | dendrite extension(GO:0097484) |
1.0 | 2.9 | GO:0097421 | liver regeneration(GO:0097421) |
1.0 | 2.9 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
1.0 | 4.8 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
1.0 | 6.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
1.0 | 56.0 | GO:0019882 | antigen processing and presentation(GO:0019882) |
1.0 | 1.0 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
1.0 | 1.0 | GO:0060346 | bone trabecula formation(GO:0060346) |
1.0 | 1.9 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
1.0 | 1.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.0 | 1.9 | GO:0007028 | cytoplasm organization(GO:0007028) |
1.0 | 1.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
1.0 | 1.9 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
1.0 | 4.8 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
1.0 | 1.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
1.0 | 1.9 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) |
1.0 | 1.0 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
1.0 | 10.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.9 | 3.8 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.9 | 20.8 | GO:0015914 | phospholipid transport(GO:0015914) |
0.9 | 0.9 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.9 | 2.8 | GO:0048659 | smooth muscle cell proliferation(GO:0048659) |
0.9 | 1.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.9 | 3.8 | GO:0032094 | response to food(GO:0032094) |
0.9 | 0.9 | GO:0002507 | tolerance induction(GO:0002507) |
0.9 | 2.8 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.9 | 5.6 | GO:0030261 | chromosome condensation(GO:0030261) |
0.9 | 0.9 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.9 | 0.9 | GO:0007567 | parturition(GO:0007567) |
0.9 | 1.9 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.9 | 1.9 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.9 | 4.7 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.9 | 1.9 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.9 | 0.9 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.9 | 0.9 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.9 | 4.6 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.9 | 1.8 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.9 | 0.9 | GO:0006826 | iron ion transport(GO:0006826) |
0.9 | 2.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.9 | 1.8 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.9 | 1.8 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.9 | 5.5 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.9 | 3.6 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.9 | 2.7 | GO:0090382 | phagosome maturation(GO:0090382) |
0.9 | 5.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.9 | 1.8 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.9 | 3.6 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.9 | 3.6 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.9 | 2.7 | GO:0001675 | acrosome assembly(GO:0001675) |
0.9 | 3.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.9 | 1.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.9 | 6.3 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.9 | 1.8 | GO:1903309 | negative regulation of chromatin modification(GO:1903309) |
0.9 | 0.9 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.9 | 18.0 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.9 | 3.6 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.9 | 11.6 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.9 | 41.9 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.9 | 1.8 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.9 | 1.8 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.9 | 8.0 | GO:0016101 | diterpenoid metabolic process(GO:0016101) |
0.9 | 1.8 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.9 | 0.9 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.9 | 4.4 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.9 | 0.9 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
0.9 | 7.0 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.9 | 0.9 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.9 | 6.1 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.9 | 96.4 | GO:0032259 | methylation(GO:0032259) |
0.9 | 1.7 | GO:0034502 | protein localization to chromosome(GO:0034502) |
0.9 | 4.4 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.9 | 1.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.9 | 9.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.9 | 0.9 | GO:0044033 | multi-organism metabolic process(GO:0044033) |
0.9 | 2.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.9 | 27.7 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
0.9 | 1.7 | GO:0031100 | organ regeneration(GO:0031100) |
0.9 | 2.6 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.9 | 1.7 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.9 | 6.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.9 | 0.9 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.9 | 4.3 | GO:0017145 | stem cell division(GO:0017145) |
0.9 | 1.7 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.9 | 42.5 | GO:0010498 | proteasomal protein catabolic process(GO:0010498) |
0.9 | 6.8 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.8 | 0.8 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.8 | 1.7 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.8 | 0.8 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.8 | 2.5 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.8 | 0.8 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.8 | 10.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.8 | 0.8 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.8 | 0.8 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.8 | 9.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.8 | 1.7 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.8 | 41.1 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.8 | 1.7 | GO:0048814 | regulation of dendrite morphogenesis(GO:0048814) |
0.8 | 32.6 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.8 | 5.8 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.8 | 0.8 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.8 | 0.8 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.8 | 5.8 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.8 | 0.8 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.8 | 54.7 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.8 | 3.3 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.8 | 0.8 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.8 | 1.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.8 | 3.3 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.8 | 0.8 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.8 | 2.5 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.8 | 3.3 | GO:0007320 | insemination(GO:0007320) |
0.8 | 2.5 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.8 | 0.8 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.8 | 5.8 | GO:0045444 | fat cell differentiation(GO:0045444) |
0.8 | 13.1 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.8 | 2.5 | GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade(GO:0070304) |
0.8 | 1.6 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.8 | 5.7 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.8 | 1.6 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.8 | 0.8 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.8 | 0.8 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
0.8 | 29.2 | GO:0007059 | chromosome segregation(GO:0007059) |
0.8 | 5.7 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.8 | 1.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.8 | 9.7 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.8 | 3.2 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.8 | 0.8 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.8 | 0.8 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.8 | 2.4 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.8 | 3.2 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.8 | 0.8 | GO:0033628 | regulation of cell adhesion mediated by integrin(GO:0033628) |
0.8 | 5.6 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.8 | 1.6 | GO:0007041 | lysosomal transport(GO:0007041) |
0.8 | 5.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.8 | 2.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.8 | 2.4 | GO:0010906 | regulation of glucose metabolic process(GO:0010906) |
0.8 | 53.1 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.8 | 2.4 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.8 | 3.2 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.8 | 33.1 | GO:0043632 | modification-dependent macromolecule catabolic process(GO:0043632) |
0.8 | 3.9 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.8 | 2.4 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.8 | 3.2 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.8 | 6.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.8 | 16.5 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.8 | 0.8 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
0.8 | 11.7 | GO:0043467 | regulation of generation of precursor metabolites and energy(GO:0043467) |
0.8 | 7.0 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.8 | 18.0 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.8 | 2.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.8 | 0.8 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.8 | 2.3 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.8 | 10.1 | GO:0043065 | positive regulation of apoptotic process(GO:0043065) |
0.8 | 0.8 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.8 | 0.8 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.8 | 1.5 | GO:0030260 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.8 | 1.5 | GO:0001757 | somite specification(GO:0001757) |
0.8 | 3.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.8 | 0.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.8 | 3.0 | GO:0016322 | neuron remodeling(GO:0016322) |
0.8 | 6.8 | GO:0042246 | tissue regeneration(GO:0042246) |
0.8 | 5.3 | GO:0036065 | fucosylation(GO:0036065) |
0.8 | 2.3 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.8 | 0.8 | GO:0060969 | negative regulation of gene silencing(GO:0060969) |
0.8 | 0.8 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.8 | 3.8 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.8 | 11.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.8 | 4.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.7 | 11.2 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.7 | 1.5 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.7 | 3.7 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.7 | 1.5 | GO:0033058 | directional locomotion(GO:0033058) |
0.7 | 3.0 | GO:0016925 | protein sumoylation(GO:0016925) |
0.7 | 4.4 | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043281) |
0.7 | 0.7 | GO:0007000 | nucleolus organization(GO:0007000) |
0.7 | 0.7 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.7 | 5.9 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.7 | 2.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.7 | 5.9 | GO:0006790 | sulfur compound metabolic process(GO:0006790) |
0.7 | 3.7 | GO:0002076 | osteoblast development(GO:0002076) |
0.7 | 4.4 | GO:0070167 | regulation of biomineral tissue development(GO:0070167) |
0.7 | 21.2 | GO:0034504 | protein localization to nucleus(GO:0034504) |
0.7 | 12.4 | GO:0014013 | regulation of gliogenesis(GO:0014013) |
0.7 | 13.2 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.7 | 1.5 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.7 | 14.6 | GO:0046330 | positive regulation of JNK cascade(GO:0046330) |
0.7 | 1.5 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.7 | 4.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.7 | 6.5 | GO:0050892 | intestinal absorption(GO:0050892) |
0.7 | 0.7 | GO:0060068 | vagina development(GO:0060068) |
0.7 | 1.4 | GO:0001841 | neural tube formation(GO:0001841) |
0.7 | 1.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.7 | 0.7 | GO:0035733 | hepatic stellate cell activation(GO:0035733) |
0.7 | 7.2 | GO:0045214 | sarcomere organization(GO:0045214) |
0.7 | 17.2 | GO:0034112 | positive regulation of homotypic cell-cell adhesion(GO:0034112) |
0.7 | 2.1 | GO:0015074 | DNA integration(GO:0015074) |
0.7 | 1.4 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.7 | 2.1 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.7 | 1.4 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.7 | 9.2 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.7 | 1.4 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.7 | 19.8 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.7 | 2.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.7 | 2.1 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.7 | 5.6 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.7 | 0.7 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.7 | 1.4 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.7 | 2.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.7 | 4.9 | GO:0016926 | protein desumoylation(GO:0016926) |
0.7 | 4.2 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.7 | 4.2 | GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal(GO:0003044) |
0.7 | 15.4 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.7 | 4.9 | GO:0048535 | lymph node development(GO:0048535) |
0.7 | 0.7 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.7 | 2.1 | GO:0031929 | TOR signaling(GO:0031929) |
0.7 | 0.7 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.7 | 1.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.7 | 0.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.7 | 67.7 | GO:0198738 | cell-cell signaling by wnt(GO:0198738) |
0.7 | 0.7 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.7 | 2.7 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.7 | 12.3 | GO:0006281 | DNA repair(GO:0006281) |
0.7 | 4.1 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.7 | 0.7 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.7 | 0.7 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.7 | 2.7 | GO:0030878 | thyroid gland development(GO:0030878) |
0.7 | 7.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.7 | 1.4 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.7 | 3.4 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.7 | 12.2 | GO:0006284 | base-excision repair(GO:0006284) |
0.7 | 1.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.7 | 13.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.7 | 2.7 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.7 | 4.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.7 | 0.7 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.7 | 0.7 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.7 | 4.6 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.7 | 1.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.7 | 4.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.7 | 0.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.7 | 1.3 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.7 | 2.0 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.7 | 5.9 | GO:0016197 | endosomal transport(GO:0016197) |
0.7 | 2.0 | GO:0001945 | lymph vessel development(GO:0001945) |
0.7 | 4.6 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.7 | 0.7 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.7 | 3.9 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.7 | 0.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.7 | 1.3 | GO:0051784 | negative regulation of mitotic nuclear division(GO:0045839) negative regulation of nuclear division(GO:0051784) |
0.7 | 43.2 | GO:0009566 | fertilization(GO:0009566) |
0.7 | 0.7 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.6 | 0.6 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.6 | 3.2 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.6 | 5.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.6 | 2.6 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.6 | 1.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.6 | 0.6 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.6 | 1.9 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.6 | 7.1 | GO:0034250 | positive regulation of cellular amide metabolic process(GO:0034250) |
0.6 | 4.5 | GO:0045639 | positive regulation of myeloid cell differentiation(GO:0045639) |
0.6 | 26.3 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.6 | 0.6 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.6 | 1.3 | GO:0010039 | response to iron ion(GO:0010039) |
0.6 | 3.8 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.6 | 1.9 | GO:0019079 | viral genome replication(GO:0019079) |
0.6 | 1.3 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.6 | 2.5 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.6 | 0.6 | GO:1902692 | regulation of neuroblast proliferation(GO:1902692) |
0.6 | 1.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.6 | 0.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.6 | 1.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.6 | 1.3 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.6 | 0.6 | GO:0018343 | protein farnesylation(GO:0018343) |
0.6 | 0.6 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.6 | 27.1 | GO:0042060 | wound healing(GO:0042060) |
0.6 | 0.6 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.6 | 15.7 | GO:0006913 | nucleocytoplasmic transport(GO:0006913) |
0.6 | 0.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.6 | 5.6 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.6 | 0.6 | GO:0016331 | morphogenesis of embryonic epithelium(GO:0016331) |
0.6 | 1.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.6 | 2.5 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.6 | 1.9 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.6 | 8.1 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.6 | 1.9 | GO:0030033 | microvillus assembly(GO:0030033) |
0.6 | 1.2 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.6 | 11.2 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.6 | 8.1 | GO:0001501 | skeletal system development(GO:0001501) |
0.6 | 1.9 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.6 | 1.9 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.6 | 2.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.6 | 0.6 | GO:0002248 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.6 | 0.6 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.6 | 6.2 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.6 | 13.0 | GO:0006909 | phagocytosis(GO:0006909) |
0.6 | 0.6 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.6 | 0.6 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.6 | 6.8 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.6 | 2.5 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.6 | 2.5 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.6 | 5.5 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.6 | 20.9 | GO:0009636 | response to toxic substance(GO:0009636) |
0.6 | 2.5 | GO:0000097 | sulfur amino acid biosynthetic process(GO:0000097) |
0.6 | 5.5 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.6 | 0.6 | GO:0010662 | regulation of striated muscle cell apoptotic process(GO:0010662) |
0.6 | 12.9 | GO:0000910 | cytokinesis(GO:0000910) |
0.6 | 1.2 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.6 | 1.2 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.6 | 1.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.6 | 17.7 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.6 | 2.4 | GO:0061515 | myeloid cell development(GO:0061515) |
0.6 | 1.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.6 | 5.5 | GO:0017144 | drug metabolic process(GO:0017144) |
0.6 | 2.4 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.6 | 2.4 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.6 | 1.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.6 | 0.6 | GO:0048102 | autophagic cell death(GO:0048102) |
0.6 | 1.2 | GO:0015893 | drug transport(GO:0015893) |
0.6 | 4.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.6 | 4.8 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.6 | 33.0 | GO:0043086 | negative regulation of catalytic activity(GO:0043086) |
0.6 | 54.6 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.6 | 15.5 | GO:0045333 | cellular respiration(GO:0045333) |
0.6 | 0.6 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.6 | 4.2 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.6 | 5.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.6 | 1.2 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
0.6 | 4.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.6 | 1.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.6 | 2.9 | GO:0001570 | vasculogenesis(GO:0001570) |
0.6 | 5.3 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.6 | 0.6 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.6 | 4.7 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.6 | 2.9 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.6 | 4.7 | GO:0006342 | chromatin silencing(GO:0006342) |
0.6 | 0.6 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.6 | 0.6 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.6 | 1.2 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.6 | 1.2 | GO:0007566 | embryo implantation(GO:0007566) |
0.6 | 2.3 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.6 | 4.1 | GO:0048286 | lung alveolus development(GO:0048286) |
0.6 | 14.5 | GO:0045089 | positive regulation of innate immune response(GO:0045089) |
0.6 | 0.6 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.6 | 0.6 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.6 | 5.8 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.6 | 19.0 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.6 | 1.7 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.6 | 10.3 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.6 | 4.0 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.6 | 0.6 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.6 | 32.0 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.6 | 4.0 | GO:0006979 | response to oxidative stress(GO:0006979) |
0.6 | 1.7 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.6 | 1.1 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.6 | 1.7 | GO:0035690 | cellular response to drug(GO:0035690) |
0.6 | 3.4 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.6 | 0.6 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.6 | 0.6 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.6 | 1.1 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
0.6 | 0.6 | GO:1903533 | regulation of protein targeting(GO:1903533) |
0.6 | 0.6 | GO:0002931 | response to ischemia(GO:0002931) |
0.6 | 12.8 | GO:0001934 | positive regulation of protein phosphorylation(GO:0001934) |
0.6 | 1.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.6 | 21.8 | GO:0060538 | skeletal muscle organ development(GO:0060538) |
0.6 | 1.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.6 | 3.3 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.6 | 6.1 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
0.6 | 1.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.6 | 14.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.6 | 0.6 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.6 | 1.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.5 | 36.8 | GO:0006396 | RNA processing(GO:0006396) |
0.5 | 8.2 | GO:0007602 | phototransduction(GO:0007602) |
0.5 | 13.2 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.5 | 4.4 | GO:0009411 | response to UV(GO:0009411) |
0.5 | 1.6 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.5 | 0.5 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.5 | 1.6 | GO:0007051 | spindle organization(GO:0007051) |
0.5 | 2.2 | GO:0009409 | response to cold(GO:0009409) |
0.5 | 1.6 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.5 | 2.7 | GO:0045619 | regulation of lymphocyte differentiation(GO:0045619) |
0.5 | 3.2 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.5 | 9.7 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.5 | 1.1 | GO:0072089 | stem cell proliferation(GO:0072089) |
0.5 | 6.4 | GO:0034329 | cell junction assembly(GO:0034329) |
0.5 | 3.7 | GO:0051180 | vitamin transport(GO:0051180) |
0.5 | 1.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.5 | 3.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.5 | 2.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.5 | 2.6 | GO:0006959 | humoral immune response(GO:0006959) |
0.5 | 3.2 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.5 | 0.5 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.5 | 1.6 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.5 | 1.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.5 | 1.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.5 | 1.6 | GO:1903729 | regulation of plasma membrane organization(GO:1903729) |
0.5 | 25.6 | GO:0070482 | response to oxygen levels(GO:0070482) |
0.5 | 1.0 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.5 | 1.0 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.5 | 3.6 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.5 | 0.5 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.5 | 0.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.5 | 1.5 | GO:0045766 | positive regulation of angiogenesis(GO:0045766) |
0.5 | 0.5 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.5 | 0.5 | GO:0032890 | regulation of organic acid transport(GO:0032890) |
0.5 | 1.5 | GO:0042640 | anagen(GO:0042640) |
0.5 | 1.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.5 | 0.5 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.5 | 4.1 | GO:0043473 | pigmentation(GO:0043473) |
0.5 | 4.6 | GO:0006805 | xenobiotic metabolic process(GO:0006805) cellular response to xenobiotic stimulus(GO:0071466) |
0.5 | 1.0 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.5 | 0.5 | GO:2001252 | positive regulation of chromosome organization(GO:2001252) |
0.5 | 0.5 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
0.5 | 0.5 | GO:0072678 | T cell migration(GO:0072678) |
0.5 | 2.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.5 | 1.5 | GO:0070166 | enamel mineralization(GO:0070166) |
0.5 | 6.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.5 | 2.0 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.5 | 5.0 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.5 | 0.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.5 | 7.0 | GO:0006575 | cellular modified amino acid metabolic process(GO:0006575) |
0.5 | 1.5 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.5 | 0.5 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.5 | 2.5 | GO:0007005 | mitochondrion organization(GO:0007005) |
0.5 | 6.5 | GO:0042098 | T cell proliferation(GO:0042098) |
0.5 | 4.4 | GO:0006022 | aminoglycan metabolic process(GO:0006022) |
0.5 | 1.0 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.5 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.5 | 1.9 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation(GO:0050731) |
0.5 | 0.5 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.5 | 1.9 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.5 | 0.5 | GO:0042439 | ethanolamine-containing compound metabolic process(GO:0042439) |
0.5 | 4.8 | GO:0071774 | response to fibroblast growth factor(GO:0071774) |
0.5 | 1.0 | GO:0032418 | lysosome localization(GO:0032418) |
0.5 | 0.5 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.5 | 1.0 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.5 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.5 | 5.7 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.5 | 4.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.5 | 2.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.5 | 0.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.5 | 0.9 | GO:0007584 | response to nutrient(GO:0007584) |
0.5 | 1.4 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.5 | 0.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.5 | 95.9 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.5 | 1.4 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) |
0.5 | 2.8 | GO:0032456 | endocytic recycling(GO:0032456) |
0.5 | 2.8 | GO:0006818 | hydrogen transport(GO:0006818) |
0.5 | 0.9 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.5 | 0.5 | GO:0043276 | anoikis(GO:0043276) |
0.5 | 0.9 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.5 | 1.4 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.5 | 0.5 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.5 | 6.9 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
0.5 | 2.3 | GO:0019319 | hexose biosynthetic process(GO:0019319) monosaccharide biosynthetic process(GO:0046364) |
0.5 | 33.9 | GO:0006897 | endocytosis(GO:0006897) |
0.5 | 5.0 | GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity(GO:0051090) |
0.5 | 1.4 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.5 | 5.4 | GO:0009408 | response to heat(GO:0009408) |
0.5 | 0.5 | GO:0046132 | pyrimidine ribonucleotide biosynthetic process(GO:0009220) pyrimidine ribonucleoside biosynthetic process(GO:0046132) |
0.5 | 1.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.5 | 5.9 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.5 | 0.5 | GO:0007379 | segment specification(GO:0007379) |
0.5 | 0.5 | GO:0015817 | histidine transport(GO:0015817) |
0.4 | 0.9 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) gamma-delta T cell activation(GO:0046629) |
0.4 | 0.4 | GO:0003170 | heart valve development(GO:0003170) |
0.4 | 0.4 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.4 | 0.4 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.4 | 0.9 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.4 | 0.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.4 | 0.4 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.4 | 0.9 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.4 | 0.4 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.4 | 0.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.4 | 3.5 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.4 | 0.4 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.4 | 0.4 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.4 | 0.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.4 | 1.7 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.4 | 0.4 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
0.4 | 0.4 | GO:0040029 | regulation of gene expression, epigenetic(GO:0040029) |
0.4 | 0.9 | GO:0030539 | male genitalia development(GO:0030539) |
0.4 | 1.7 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.4 | 2.2 | GO:0042493 | response to drug(GO:0042493) |
0.4 | 18.7 | GO:0006260 | DNA replication(GO:0006260) |
0.4 | 3.0 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.4 | 0.9 | GO:0050832 | defense response to fungus(GO:0050832) |
0.4 | 0.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.4 | 0.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.4 | 0.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.4 | 0.4 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.4 | 0.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.4 | 0.4 | GO:0046541 | saliva secretion(GO:0046541) |
0.4 | 4.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.4 | 0.4 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.4 | 2.5 | GO:0051402 | neuron apoptotic process(GO:0051402) |
0.4 | 0.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.4 | 1.3 | GO:0045637 | regulation of myeloid cell differentiation(GO:0045637) |
0.4 | 0.4 | GO:0035425 | autocrine signaling(GO:0035425) |
0.4 | 2.9 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.4 | 1.7 | GO:0009994 | oocyte differentiation(GO:0009994) |
0.4 | 0.8 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.4 | 10.3 | GO:0071241 | cellular response to inorganic substance(GO:0071241) |
0.4 | 0.4 | GO:0001657 | ureteric bud development(GO:0001657) mesonephros development(GO:0001823) mesonephric epithelium development(GO:0072163) mesonephric tubule development(GO:0072164) |
0.4 | 0.4 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
0.4 | 5.3 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.4 | 0.4 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.4 | 0.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.4 | 0.4 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.4 | 1.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.4 | 0.4 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
0.4 | 18.6 | GO:0016568 | chromatin modification(GO:0016568) |
0.4 | 0.4 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.4 | 7.9 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.4 | 0.4 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.4 | 0.4 | GO:0046427 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.4 | 0.8 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.4 | 3.9 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.4 | 1.2 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.4 | 1.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.4 | 0.4 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.4 | 0.4 | GO:0045123 | cellular extravasation(GO:0045123) |
0.4 | 0.4 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.4 | 0.4 | GO:0060022 | hard palate development(GO:0060022) |
0.4 | 1.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.4 | 4.2 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.4 | 0.4 | GO:0000723 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.4 | 0.8 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.4 | 1.1 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.4 | 1.5 | GO:0010171 | body morphogenesis(GO:0010171) |
0.4 | 12.2 | GO:1903008 | organelle disassembly(GO:1903008) |
0.4 | 0.8 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.4 | 0.4 | GO:0051181 | cofactor transport(GO:0051181) |
0.4 | 0.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.4 | 2.6 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.4 | 10.6 | GO:0044257 | cellular protein catabolic process(GO:0044257) |
0.4 | 0.8 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.4 | 0.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.4 | 0.7 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.4 | 0.4 | GO:0030879 | mammary gland development(GO:0030879) |
0.4 | 3.0 | GO:0030317 | sperm motility(GO:0030317) |
0.4 | 4.8 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
0.4 | 0.4 | GO:1903900 | regulation of viral life cycle(GO:1903900) |
0.4 | 2.6 | GO:0009185 | ribonucleoside diphosphate metabolic process(GO:0009185) |
0.4 | 1.8 | GO:0051592 | response to calcium ion(GO:0051592) |
0.4 | 0.4 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.4 | 22.7 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.4 | 1.5 | GO:0050878 | regulation of body fluid levels(GO:0050878) |
0.4 | 5.1 | GO:0046434 | organophosphate catabolic process(GO:0046434) |
0.4 | 26.9 | GO:0045087 | innate immune response(GO:0045087) |
0.4 | 0.7 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) |
0.4 | 1.8 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.4 | 13.8 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.4 | 1.4 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.4 | 0.4 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.4 | 12.2 | GO:0007601 | visual perception(GO:0007601) |
0.4 | 1.4 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.4 | 16.0 | GO:0006869 | lipid transport(GO:0006869) |
0.4 | 1.8 | GO:0018212 | peptidyl-tyrosine modification(GO:0018212) |
0.4 | 1.4 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.4 | 2.8 | GO:0019835 | cytolysis(GO:0019835) |
0.4 | 3.9 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.4 | 0.4 | GO:0060525 | epithelial cell maturation(GO:0002070) prostate glandular acinus development(GO:0060525) epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.4 | 2.5 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.4 | 0.7 | GO:0006091 | generation of precursor metabolites and energy(GO:0006091) |
0.4 | 5.6 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.4 | 0.4 | GO:0001553 | luteinization(GO:0001553) |
0.4 | 0.7 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.3 | 0.3 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) |
0.3 | 3.8 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 38.7 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.3 | 0.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 2.4 | GO:0006974 | cellular response to DNA damage stimulus(GO:0006974) |
0.3 | 0.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.3 | 22.1 | GO:0051260 | protein homooligomerization(GO:0051260) |
0.3 | 9.7 | GO:0002237 | response to molecule of bacterial origin(GO:0002237) |
0.3 | 1.0 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.3 | 17.5 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.3 | 283.3 | GO:0006351 | transcription, DNA-templated(GO:0006351) |
0.3 | 0.7 | GO:0015837 | amine transport(GO:0015837) |
0.3 | 0.7 | GO:0046496 | nicotinamide nucleotide metabolic process(GO:0046496) |
0.3 | 1.0 | GO:0051099 | positive regulation of binding(GO:0051099) |
0.3 | 2.0 | GO:0097190 | apoptotic signaling pathway(GO:0097190) |
0.3 | 2.3 | GO:0021675 | nerve development(GO:0021675) |
0.3 | 0.7 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.3 | 0.7 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.3 | 0.3 | GO:0090130 | tissue migration(GO:0090130) |
0.3 | 0.3 | GO:0046631 | alpha-beta T cell activation(GO:0046631) |
0.3 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.3 | 0.6 | GO:1905037 | autophagosome organization(GO:1905037) |
0.3 | 3.2 | GO:0042594 | response to starvation(GO:0042594) |
0.3 | 1.6 | GO:0046849 | bone remodeling(GO:0046849) |
0.3 | 0.3 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.3 | 0.3 | GO:0043331 | response to dsRNA(GO:0043331) |
0.3 | 0.6 | GO:1901607 | alpha-amino acid biosynthetic process(GO:1901607) |
0.3 | 0.3 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.3 | 0.3 | GO:0042451 | purine nucleoside biosynthetic process(GO:0042451) purine ribonucleoside biosynthetic process(GO:0046129) |
0.3 | 0.3 | GO:0048806 | genitalia development(GO:0048806) |
0.3 | 0.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 0.3 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.3 | 0.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 0.9 | GO:0006949 | syncytium formation(GO:0006949) |
0.3 | 2.1 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) |
0.3 | 0.9 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.3 | 0.3 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.3 | 0.6 | GO:0019439 | aromatic compound catabolic process(GO:0019439) |
0.3 | 0.3 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.3 | 0.3 | GO:0042440 | pigment metabolic process(GO:0042440) |
0.3 | 0.8 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 0.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.3 | 0.3 | GO:0030431 | sleep(GO:0030431) |
0.3 | 1.3 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.3 | 1.3 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.3 | 5.7 | GO:0043066 | negative regulation of apoptotic process(GO:0043066) |
0.3 | 1.0 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.3 | 0.3 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.3 | 0.3 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.3 | 4.3 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.3 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 2.7 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.2 | 0.7 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.2 | 1.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.2 | 30.9 | GO:0016310 | phosphorylation(GO:0016310) |
0.2 | 8.7 | GO:0070085 | glycosylation(GO:0070085) |
0.2 | 1.2 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 14.0 | GO:0012501 | programmed cell death(GO:0012501) |
0.2 | 0.2 | GO:0032675 | regulation of interleukin-6 production(GO:0032675) |
0.2 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.2 | 0.2 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.2 | 0.2 | GO:0001967 | suckling behavior(GO:0001967) |
0.2 | 0.2 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.2 | 0.4 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.2 | 0.2 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.2 | 28.2 | GO:0006412 | translation(GO:0006412) |
0.2 | 0.2 | GO:0051781 | positive regulation of cell division(GO:0051781) |
0.2 | 0.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 0.2 | GO:0048489 | synaptic vesicle transport(GO:0048489) establishment of synaptic vesicle localization(GO:0097480) |
0.2 | 0.2 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.2 | 0.2 | GO:0006497 | protein lipidation(GO:0006497) |
0.2 | 0.2 | GO:0048145 | regulation of fibroblast proliferation(GO:0048145) |
0.2 | 0.4 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 0.2 | GO:0045862 | positive regulation of proteolysis(GO:0045862) |
0.2 | 0.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 20.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.2 | 0.6 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.2 | 0.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 8.6 | GO:0007049 | cell cycle(GO:0007049) |
0.2 | 1.2 | GO:0002768 | immune response-regulating cell surface receptor signaling pathway(GO:0002768) |
0.2 | 0.6 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.2 | 0.4 | GO:0001890 | placenta development(GO:0001890) |
0.2 | 0.4 | GO:0032328 | alanine transport(GO:0032328) |
0.2 | 0.2 | GO:0007614 | short-term memory(GO:0007614) |
0.2 | 0.4 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.2 | 1.3 | GO:1901652 | response to peptide(GO:1901652) |
0.2 | 0.2 | GO:0007492 | endoderm development(GO:0007492) |
0.2 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 0.2 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.2 | 0.2 | GO:0061448 | connective tissue development(GO:0061448) |
0.2 | 0.2 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.2 | 0.2 | GO:0070206 | protein trimerization(GO:0070206) |
0.2 | 0.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.2 | GO:0031641 | regulation of myelination(GO:0031641) |
0.2 | 0.5 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.2 | 0.2 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.2 | 0.3 | GO:0042048 | olfactory behavior(GO:0042048) |
0.2 | 0.2 | GO:2000112 | regulation of cellular macromolecule biosynthetic process(GO:2000112) |
0.2 | 4.1 | GO:0006814 | sodium ion transport(GO:0006814) |
0.2 | 7.1 | GO:0001101 | response to acid chemical(GO:0001101) |
0.2 | 0.3 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.2 | 0.2 | GO:0071711 | basement membrane organization(GO:0071711) |
0.2 | 0.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.1 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 0.1 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 158.7 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.1 | 0.1 | GO:0071383 | cellular response to steroid hormone stimulus(GO:0071383) |
0.1 | 0.4 | GO:0031638 | zymogen activation(GO:0031638) |
0.1 | 0.5 | GO:0050906 | detection of stimulus involved in sensory perception(GO:0050906) |
0.1 | 0.1 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122) |
0.1 | 0.4 | GO:0070997 | neuron death(GO:0070997) |
0.1 | 1.6 | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway(GO:0007169) |
0.1 | 0.1 | GO:0051251 | positive regulation of lymphocyte activation(GO:0051251) |
0.1 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.2 | GO:0042044 | fluid transport(GO:0042044) |
0.1 | 0.1 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.1 | 0.1 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.1 | 0.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.1 | GO:0007565 | female pregnancy(GO:0007565) |
0.1 | 0.1 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 1.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.4 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 2.0 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.1 | 1.2 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
0.1 | 0.3 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.1 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.1 | GO:0003014 | renal system process(GO:0003014) |
0.1 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.1 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.1 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.1 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.1 | 0.1 | GO:0016052 | carbohydrate catabolic process(GO:0016052) |
0.1 | 0.1 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.1 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.1 | GO:0048483 | autonomic nervous system development(GO:0048483) |
0.1 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.2 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:0002067 | glandular epithelial cell differentiation(GO:0002067) |
0.0 | 0.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.1 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
0.0 | 0.0 | GO:0019058 | viral life cycle(GO:0019058) |
0.0 | 0.0 | GO:0042107 | cytokine metabolic process(GO:0042107) |
0.0 | 9.9 | GO:0019538 | protein metabolic process(GO:0019538) |
0.0 | 0.0 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.0 | 0.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.4 | GO:0016311 | dephosphorylation(GO:0016311) |
0.0 | 0.0 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.0 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.0 | 0.1 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.3 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.0 | 0.0 | GO:0042476 | odontogenesis(GO:0042476) |
0.0 | 0.3 | GO:0051252 | regulation of RNA metabolic process(GO:0051252) |
0.0 | 0.0 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
0.0 | 0.0 | GO:1903706 | regulation of hemopoiesis(GO:1903706) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
34.9 | 104.6 | GO:0097413 | Lewy body(GO:0097413) |
13.3 | 40.0 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
13.1 | 65.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
11.1 | 33.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
9.4 | 47.0 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
9.2 | 36.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
8.3 | 24.9 | GO:0070552 | BRISC complex(GO:0070552) |
7.6 | 53.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
7.6 | 22.8 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
7.5 | 7.5 | GO:0000125 | PCAF complex(GO:0000125) |
7.4 | 22.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
7.2 | 108.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
7.1 | 28.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
7.1 | 49.9 | GO:0090543 | Flemming body(GO:0090543) |
7.0 | 34.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
6.9 | 20.6 | GO:0005606 | laminin-1 complex(GO:0005606) |
6.7 | 20.1 | GO:0097513 | myosin II filament(GO:0097513) |
6.7 | 6.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
6.6 | 19.7 | GO:0097443 | sorting endosome(GO:0097443) |
5.8 | 35.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
5.6 | 5.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
5.5 | 22.0 | GO:0032437 | cuticular plate(GO:0032437) |
5.5 | 16.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
5.4 | 16.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
5.2 | 26.2 | GO:0005638 | lamin filament(GO:0005638) |
5.2 | 20.6 | GO:0097452 | GAIT complex(GO:0097452) |
5.1 | 41.0 | GO:0005861 | troponin complex(GO:0005861) |
5.1 | 10.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
5.1 | 10.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
5.0 | 15.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
5.0 | 19.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
4.9 | 14.8 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
4.9 | 14.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
4.8 | 53.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
4.7 | 14.2 | GO:0005955 | calcineurin complex(GO:0005955) |
4.7 | 89.5 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
4.6 | 18.2 | GO:0045298 | tubulin complex(GO:0045298) |
4.5 | 36.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
4.5 | 4.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
4.3 | 60.6 | GO:0000974 | Prp19 complex(GO:0000974) |
4.2 | 33.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
4.2 | 21.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
4.2 | 62.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
4.1 | 20.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
4.1 | 48.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
4.0 | 16.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
4.0 | 39.9 | GO:0031010 | ISWI-type complex(GO:0031010) |
4.0 | 27.7 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
3.9 | 15.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
3.9 | 19.4 | GO:0045180 | basal cortex(GO:0045180) |
3.9 | 19.3 | GO:0005827 | polar microtubule(GO:0005827) |
3.8 | 11.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
3.8 | 3.8 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
3.8 | 33.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
3.8 | 11.3 | GO:0005712 | chiasma(GO:0005712) |
3.7 | 37.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
3.7 | 3.7 | GO:0042585 | germinal vesicle(GO:0042585) |
3.7 | 22.3 | GO:0005915 | zonula adherens(GO:0005915) |
3.6 | 47.4 | GO:0031528 | microvillus membrane(GO:0031528) |
3.6 | 68.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
3.5 | 14.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
3.5 | 10.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
3.5 | 31.5 | GO:0071439 | clathrin complex(GO:0071439) |
3.5 | 76.6 | GO:0000786 | nucleosome(GO:0000786) |
3.5 | 20.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
3.5 | 10.4 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
3.4 | 3.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
3.4 | 118.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
3.4 | 10.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
3.3 | 13.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
3.2 | 19.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
3.2 | 9.7 | GO:0016342 | catenin complex(GO:0016342) |
3.2 | 12.9 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
3.2 | 9.6 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
3.2 | 9.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
3.2 | 22.3 | GO:0030056 | hemidesmosome(GO:0030056) |
3.2 | 9.6 | GO:0005745 | m-AAA complex(GO:0005745) |
3.1 | 25.2 | GO:0045179 | apical cortex(GO:0045179) |
3.1 | 25.1 | GO:0030426 | growth cone(GO:0030426) |
3.1 | 12.5 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
3.1 | 12.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
3.0 | 3.0 | GO:0001651 | dense fibrillar component(GO:0001651) |
3.0 | 24.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
3.0 | 42.0 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
3.0 | 42.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
3.0 | 41.9 | GO:0051233 | spindle midzone(GO:0051233) |
3.0 | 32.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
3.0 | 11.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
3.0 | 38.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
3.0 | 5.9 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
2.9 | 17.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
2.9 | 26.4 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
2.9 | 20.5 | GO:0005916 | fascia adherens(GO:0005916) |
2.9 | 8.8 | GO:0032010 | phagolysosome(GO:0032010) |
2.9 | 8.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
2.9 | 29.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
2.9 | 2.9 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
2.9 | 11.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
2.9 | 8.7 | GO:0032444 | activin responsive factor complex(GO:0032444) |
2.9 | 8.7 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
2.9 | 2.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
2.9 | 8.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
2.9 | 5.8 | GO:0032127 | dense core granule membrane(GO:0032127) |
2.9 | 126.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
2.9 | 131.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
2.8 | 22.8 | GO:0005844 | polysome(GO:0005844) |
2.8 | 8.5 | GO:0000235 | astral microtubule(GO:0000235) |
2.8 | 14.2 | GO:0043219 | lateral loop(GO:0043219) |
2.8 | 19.8 | GO:0016272 | prefoldin complex(GO:0016272) |
2.8 | 28.2 | GO:0031143 | pseudopodium(GO:0031143) |
2.8 | 30.7 | GO:0044232 | organelle membrane contact site(GO:0044232) |
2.7 | 8.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
2.7 | 21.9 | GO:0030673 | axolemma(GO:0030673) |
2.7 | 156.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
2.7 | 8.0 | GO:0097470 | ribbon synapse(GO:0097470) |
2.6 | 7.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
2.6 | 23.8 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
2.6 | 5.3 | GO:0071564 | npBAF complex(GO:0071564) |
2.6 | 174.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
2.6 | 18.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
2.6 | 36.6 | GO:0005682 | U5 snRNP(GO:0005682) |
2.6 | 31.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
2.6 | 36.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
2.6 | 44.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
2.6 | 36.0 | GO:0043034 | costamere(GO:0043034) |
2.6 | 53.9 | GO:0031941 | filamentous actin(GO:0031941) |
2.6 | 2.6 | GO:0000938 | GARP complex(GO:0000938) |
2.5 | 53.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
2.5 | 17.6 | GO:0005694 | chromosome(GO:0005694) |
2.5 | 32.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
2.5 | 10.1 | GO:0071953 | elastic fiber(GO:0071953) |
2.5 | 17.4 | GO:0005688 | U6 snRNP(GO:0005688) |
2.5 | 19.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
2.4 | 31.8 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
2.4 | 31.7 | GO:0031430 | M band(GO:0031430) |
2.4 | 31.5 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
2.4 | 12.0 | GO:0030870 | Mre11 complex(GO:0030870) |
2.4 | 7.2 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
2.4 | 140.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
2.4 | 2.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
2.4 | 23.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
2.4 | 21.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
2.4 | 4.7 | GO:1990635 | proximal dendrite(GO:1990635) |
2.4 | 7.1 | GO:0016939 | kinesin II complex(GO:0016939) |
2.3 | 2.3 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
2.3 | 46.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
2.3 | 11.7 | GO:0034709 | methylosome(GO:0034709) |
2.3 | 7.0 | GO:0089701 | U2AF(GO:0089701) |
2.3 | 11.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
2.3 | 9.3 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
2.3 | 27.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
2.3 | 427.5 | GO:0016604 | nuclear body(GO:0016604) |
2.3 | 22.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
2.3 | 20.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
2.3 | 6.8 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
2.2 | 58.3 | GO:0031985 | Golgi cisterna(GO:0031985) |
2.2 | 35.8 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
2.2 | 4.4 | GO:0005642 | annulate lamellae(GO:0005642) |
2.2 | 13.3 | GO:0032994 | protein-lipid complex(GO:0032994) |
2.2 | 28.6 | GO:0035869 | ciliary transition zone(GO:0035869) |
2.2 | 65.7 | GO:0000792 | heterochromatin(GO:0000792) |
2.2 | 19.6 | GO:1990204 | oxidoreductase complex(GO:1990204) |
2.2 | 56.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
2.2 | 75.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
2.2 | 28.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
2.1 | 12.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
2.1 | 33.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
2.1 | 84.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
2.1 | 46.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
2.1 | 8.3 | GO:0071565 | nBAF complex(GO:0071565) |
2.1 | 2.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
2.1 | 20.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
2.1 | 6.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
2.0 | 8.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
2.0 | 40.9 | GO:0008305 | integrin complex(GO:0008305) |
2.0 | 61.3 | GO:0031901 | early endosome membrane(GO:0031901) |
2.0 | 12.2 | GO:1990752 | microtubule plus-end(GO:0035371) microtubule end(GO:1990752) |
2.0 | 4.1 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
2.0 | 6.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
2.0 | 6.0 | GO:0000346 | transcription export complex(GO:0000346) |
2.0 | 2.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
2.0 | 17.7 | GO:0005869 | dynactin complex(GO:0005869) |
2.0 | 25.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
1.9 | 15.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
1.9 | 3.8 | GO:0000322 | storage vacuole(GO:0000322) |
1.9 | 3.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.9 | 9.5 | GO:0031209 | SCAR complex(GO:0031209) |
1.9 | 120.7 | GO:0030018 | Z disc(GO:0030018) |
1.9 | 5.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.9 | 9.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
1.9 | 18.7 | GO:0005675 | holo TFIIH complex(GO:0005675) |
1.9 | 20.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
1.9 | 5.6 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
1.9 | 5.6 | GO:0070938 | contractile ring(GO:0070938) |
1.9 | 11.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
1.9 | 9.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
1.9 | 20.5 | GO:0032039 | integrator complex(GO:0032039) |
1.9 | 11.2 | GO:0000801 | central element(GO:0000801) |
1.9 | 35.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
1.9 | 88.8 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
1.8 | 9.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.8 | 5.5 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
1.8 | 1.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.8 | 3.7 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.8 | 3.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
1.8 | 9.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
1.8 | 7.3 | GO:0005874 | microtubule(GO:0005874) |
1.8 | 25.5 | GO:0031519 | PcG protein complex(GO:0031519) |
1.8 | 9.1 | GO:0042629 | mast cell granule(GO:0042629) |
1.8 | 9.0 | GO:0005579 | membrane attack complex(GO:0005579) |
1.8 | 37.7 | GO:0016592 | mediator complex(GO:0016592) |
1.8 | 7.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
1.8 | 69.6 | GO:0016363 | nuclear matrix(GO:0016363) |
1.8 | 8.9 | GO:0030315 | T-tubule(GO:0030315) |
1.8 | 413.5 | GO:0005925 | focal adhesion(GO:0005925) |
1.8 | 23.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
1.8 | 14.0 | GO:0002102 | podosome(GO:0002102) |
1.7 | 5.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
1.7 | 8.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
1.7 | 12.2 | GO:0043083 | synaptic cleft(GO:0043083) |
1.7 | 10.4 | GO:0036464 | cytoplasmic ribonucleoprotein granule(GO:0036464) |
1.7 | 6.9 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
1.7 | 31.1 | GO:0005922 | connexon complex(GO:0005922) |
1.7 | 255.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
1.7 | 6.9 | GO:0043218 | compact myelin(GO:0043218) |
1.7 | 8.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.7 | 5.2 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.7 | 1.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.7 | 597.6 | GO:0005813 | centrosome(GO:0005813) |
1.7 | 71.6 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
1.7 | 5.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
1.7 | 10.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.7 | 1.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.6 | 13.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
1.6 | 12.9 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
1.6 | 3.2 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.6 | 1.6 | GO:0045177 | apical part of cell(GO:0045177) |
1.6 | 30.3 | GO:0001772 | immunological synapse(GO:0001772) |
1.6 | 12.6 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
1.6 | 11.0 | GO:0031932 | TORC2 complex(GO:0031932) |
1.6 | 195.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
1.6 | 4.7 | GO:0044194 | cytolytic granule(GO:0044194) |
1.6 | 3.1 | GO:0000805 | X chromosome(GO:0000805) |
1.6 | 6.2 | GO:0001939 | female pronucleus(GO:0001939) male pronucleus(GO:0001940) |
1.6 | 14.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
1.5 | 381.6 | GO:0005667 | transcription factor complex(GO:0005667) |
1.5 | 1.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.5 | 4.6 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
1.5 | 10.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.5 | 12.2 | GO:0036157 | outer dynein arm(GO:0036157) |
1.5 | 60.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
1.5 | 25.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.5 | 13.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
1.5 | 4.5 | GO:0031417 | NatC complex(GO:0031417) |
1.5 | 15.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
1.5 | 13.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.5 | 9.0 | GO:0005796 | Golgi lumen(GO:0005796) |
1.5 | 29.8 | GO:0016235 | aggresome(GO:0016235) |
1.5 | 8.9 | GO:0030057 | desmosome(GO:0030057) |
1.5 | 1.5 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
1.5 | 4.4 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.5 | 4.4 | GO:0031415 | NatA complex(GO:0031415) |
1.5 | 5.9 | GO:0005902 | microvillus(GO:0005902) |
1.5 | 2.9 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
1.5 | 52.6 | GO:0016459 | myosin complex(GO:0016459) |
1.4 | 15.9 | GO:0044420 | extracellular matrix component(GO:0044420) |
1.4 | 39.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
1.4 | 2.9 | GO:0070820 | tertiary granule(GO:0070820) |
1.4 | 14.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
1.4 | 4.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.4 | 1.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.4 | 1535.9 | GO:0005739 | mitochondrion(GO:0005739) |
1.4 | 5.6 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.4 | 152.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
1.4 | 1268.9 | GO:0005654 | nucleoplasm(GO:0005654) |
1.4 | 20.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
1.4 | 6.9 | GO:0042383 | sarcolemma(GO:0042383) |
1.4 | 4.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
1.4 | 400.7 | GO:0005730 | nucleolus(GO:0005730) |
1.4 | 2.7 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
1.4 | 5.5 | GO:0042641 | actomyosin(GO:0042641) |
1.4 | 92.5 | GO:0043296 | apical junction complex(GO:0043296) |
1.4 | 18.9 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
1.3 | 14.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.3 | 13.4 | GO:0042599 | lamellar body(GO:0042599) |
1.3 | 50.8 | GO:0055037 | recycling endosome(GO:0055037) |
1.3 | 3.9 | GO:1990130 | Iml1 complex(GO:1990130) |
1.3 | 5.2 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
1.3 | 1.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
1.3 | 3.9 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.3 | 2.6 | GO:0000502 | proteasome complex(GO:0000502) |
1.3 | 9.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.3 | 28.0 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
1.3 | 300.6 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
1.3 | 1.3 | GO:1990696 | USH2 complex(GO:1990696) |
1.3 | 2.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.3 | 5.0 | GO:0045178 | basal part of cell(GO:0045178) |
1.3 | 15.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.2 | 8.7 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
1.2 | 894.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
1.2 | 2.4 | GO:0031983 | vesicle lumen(GO:0031983) |
1.2 | 101.9 | GO:0016324 | apical plasma membrane(GO:0016324) |
1.2 | 4.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.2 | 2.4 | GO:0001674 | female germ cell nucleus(GO:0001674) |
1.2 | 8.3 | GO:0072686 | mitotic spindle(GO:0072686) |
1.2 | 15.4 | GO:0005811 | lipid particle(GO:0005811) |
1.2 | 3.5 | GO:0030897 | HOPS complex(GO:0030897) |
1.2 | 2.3 | GO:0030904 | retromer complex(GO:0030904) |
1.2 | 4.7 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
1.2 | 2.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.2 | 38.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
1.2 | 15.1 | GO:0036064 | ciliary basal body(GO:0036064) |
1.2 | 67.2 | GO:0005581 | collagen trimer(GO:0005581) |
1.2 | 2.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
1.2 | 4.6 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
1.1 | 2.3 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
1.1 | 2.3 | GO:0005914 | spot adherens junction(GO:0005914) |
1.1 | 9.1 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
1.1 | 2.3 | GO:0016600 | flotillin complex(GO:0016600) |
1.1 | 5.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
1.1 | 3.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.1 | 1.1 | GO:0033270 | paranode region of axon(GO:0033270) |
1.1 | 4.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
1.1 | 2514.6 | GO:0005634 | nucleus(GO:0005634) |
1.1 | 1.1 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.1 | 7.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.1 | 2.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.0 | 7.3 | GO:0036128 | CatSper complex(GO:0036128) |
1.0 | 8.4 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
1.0 | 9.3 | GO:0001527 | microfibril(GO:0001527) |
1.0 | 1.0 | GO:0097422 | tubular endosome(GO:0097422) |
1.0 | 27.6 | GO:0043231 | intracellular membrane-bounded organelle(GO:0043231) |
1.0 | 4.1 | GO:0043025 | neuronal cell body(GO:0043025) |
1.0 | 34.3 | GO:0005770 | late endosome(GO:0005770) |
1.0 | 8.1 | GO:0044291 | cell-cell contact zone(GO:0044291) |
1.0 | 3.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
1.0 | 6.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.0 | 2.0 | GO:0043511 | inhibin complex(GO:0043511) |
1.0 | 1.0 | GO:0044292 | dendrite terminus(GO:0044292) |
1.0 | 2.9 | GO:0045171 | intercellular bridge(GO:0045171) |
0.9 | 3.8 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.9 | 2.8 | GO:0034464 | BBSome(GO:0034464) |
0.9 | 23.2 | GO:0012505 | endomembrane system(GO:0012505) |
0.9 | 329.7 | GO:0005829 | cytosol(GO:0005829) |
0.9 | 23.0 | GO:0031514 | motile cilium(GO:0031514) |
0.9 | 1.8 | GO:1990923 | PET complex(GO:1990923) |
0.9 | 25.7 | GO:0010008 | endosome membrane(GO:0010008) |
0.9 | 124.7 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.9 | 7.3 | GO:0043196 | varicosity(GO:0043196) |
0.9 | 4.5 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.9 | 726.3 | GO:0070062 | extracellular exosome(GO:0070062) |
0.9 | 1.8 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.9 | 3.6 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.9 | 12.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.9 | 2.6 | GO:0000922 | spindle pole(GO:0000922) |
0.9 | 9.4 | GO:0031252 | cell leading edge(GO:0031252) |
0.8 | 1.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.8 | 18.7 | GO:0005911 | cell-cell junction(GO:0005911) |
0.8 | 2.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.8 | 0.8 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.8 | 6.4 | GO:0043234 | protein complex(GO:0043234) |
0.8 | 7.9 | GO:0030286 | dynein complex(GO:0030286) |
0.8 | 1237.0 | GO:0005737 | cytoplasm(GO:0005737) |
0.8 | 0.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.7 | 2.8 | GO:0030054 | cell junction(GO:0030054) |
0.7 | 3.5 | GO:0031982 | vesicle(GO:0031982) |
0.7 | 0.7 | GO:0097255 | R2TP complex(GO:0097255) |
0.6 | 6.0 | GO:0005903 | brush border(GO:0005903) |
0.6 | 1.8 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.6 | 4.7 | GO:0043005 | neuron projection(GO:0043005) |
0.6 | 1.7 | GO:0043197 | dendritic spine(GO:0043197) |
0.6 | 5.0 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.5 | 1.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.5 | 0.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 0.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 42.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.4 | 94.8 | GO:0009986 | cell surface(GO:0009986) |
0.4 | 0.8 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.4 | 1052.2 | GO:0016021 | integral component of membrane(GO:0016021) |
0.4 | 121.4 | GO:0005615 | extracellular space(GO:0005615) |
0.4 | 2.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.3 | 85.6 | GO:0016020 | membrane(GO:0016020) |
0.3 | 4.7 | GO:0045095 | keratin filament(GO:0045095) |
0.3 | 0.3 | GO:0005819 | spindle(GO:0005819) |
0.3 | 98.4 | GO:0005576 | extracellular region(GO:0005576) |
0.3 | 0.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 33.6 | GO:0005623 | cell(GO:0005623) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
22.9 | 68.8 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
21.7 | 65.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
18.0 | 54.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
16.8 | 134.5 | GO:0008430 | selenium binding(GO:0008430) |
14.6 | 43.9 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
14.5 | 43.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
13.7 | 13.7 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
13.5 | 53.8 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
13.4 | 40.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
13.3 | 40.0 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
12.7 | 38.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
12.1 | 12.1 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
11.6 | 34.8 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
11.3 | 11.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
11.2 | 33.6 | GO:0030172 | troponin C binding(GO:0030172) |
11.0 | 32.9 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
10.7 | 32.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
10.5 | 21.0 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
10.5 | 31.4 | GO:0048030 | disaccharide binding(GO:0048030) |
9.9 | 187.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
9.8 | 39.4 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
9.6 | 57.9 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
9.5 | 57.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
9.5 | 28.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
9.4 | 46.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
8.6 | 34.4 | GO:0031720 | haptoglobin binding(GO:0031720) |
8.1 | 24.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
8.1 | 24.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
8.1 | 32.3 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
7.9 | 39.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
7.7 | 23.2 | GO:0008142 | oxysterol binding(GO:0008142) |
7.7 | 38.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
7.5 | 45.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
7.5 | 60.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
7.4 | 22.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
7.1 | 21.4 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
7.1 | 21.4 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
7.0 | 21.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
7.0 | 13.9 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
6.9 | 41.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
6.8 | 20.4 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
6.7 | 33.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
6.6 | 13.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
6.6 | 19.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
6.5 | 45.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
6.5 | 13.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
6.3 | 25.3 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
6.3 | 94.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
6.3 | 94.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
6.2 | 18.7 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
5.9 | 17.7 | GO:0043199 | sulfate binding(GO:0043199) |
5.9 | 23.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
5.8 | 28.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
5.7 | 17.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
5.6 | 28.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
5.6 | 16.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
5.5 | 27.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
5.5 | 16.5 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
5.4 | 81.6 | GO:0030275 | LRR domain binding(GO:0030275) |
5.3 | 85.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
5.3 | 42.5 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
5.3 | 15.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
5.3 | 15.8 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
5.3 | 26.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
5.2 | 20.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
5.1 | 20.3 | GO:0043515 | kinetochore binding(GO:0043515) |
5.1 | 15.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
5.0 | 20.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
5.0 | 25.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
5.0 | 15.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
5.0 | 30.0 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
5.0 | 34.8 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
5.0 | 19.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
4.9 | 19.7 | GO:0042731 | PH domain binding(GO:0042731) |
4.9 | 19.7 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
4.9 | 19.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
4.9 | 14.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
4.9 | 29.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
4.8 | 57.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
4.8 | 9.6 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
4.7 | 32.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
4.7 | 79.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
4.7 | 9.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
4.6 | 18.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
4.6 | 13.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
4.6 | 22.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
4.6 | 196.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
4.6 | 18.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
4.6 | 18.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
4.5 | 27.1 | GO:0030274 | LIM domain binding(GO:0030274) |
4.5 | 13.4 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
4.4 | 93.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
4.4 | 17.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
4.4 | 17.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
4.4 | 30.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
4.3 | 38.5 | GO:0052685 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
4.3 | 34.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
4.2 | 12.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
4.2 | 4.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
4.1 | 107.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
4.1 | 36.8 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
4.1 | 4.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
4.0 | 16.0 | GO:0009374 | biotin binding(GO:0009374) |
4.0 | 4.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
4.0 | 11.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
4.0 | 119.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
3.9 | 3.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
3.9 | 19.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
3.8 | 22.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
3.8 | 15.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
3.8 | 26.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
3.7 | 3.7 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
3.7 | 29.8 | GO:0042557 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
3.7 | 11.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
3.7 | 14.8 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
3.7 | 14.8 | GO:0019237 | centromeric DNA binding(GO:0019237) |
3.7 | 25.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
3.7 | 11.0 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
3.7 | 14.7 | GO:1990239 | steroid hormone binding(GO:1990239) |
3.7 | 11.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
3.6 | 39.3 | GO:0017166 | vinculin binding(GO:0017166) |
3.6 | 10.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
3.5 | 39.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
3.5 | 14.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
3.5 | 20.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
3.4 | 17.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
3.4 | 20.6 | GO:0030983 | mismatched DNA binding(GO:0030983) |
3.4 | 20.6 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
3.4 | 17.1 | GO:0016530 | metallochaperone activity(GO:0016530) |
3.4 | 10.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
3.4 | 23.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
3.4 | 47.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
3.4 | 10.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
3.3 | 72.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
3.3 | 49.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
3.3 | 79.1 | GO:0030515 | snoRNA binding(GO:0030515) |
3.3 | 26.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
3.3 | 3.3 | GO:0016918 | retinal binding(GO:0016918) |
3.3 | 26.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
3.3 | 6.5 | GO:0038132 | neuregulin binding(GO:0038132) |
3.2 | 3.2 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
3.2 | 42.2 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
3.2 | 9.7 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
3.2 | 12.8 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
3.2 | 16.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
3.2 | 3.2 | GO:0051183 | vitamin transporter activity(GO:0051183) |
3.2 | 15.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
3.2 | 22.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
3.2 | 19.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
3.2 | 9.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
3.2 | 22.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
3.2 | 31.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
3.1 | 9.4 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
3.1 | 9.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
3.1 | 37.3 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
3.1 | 18.6 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
3.0 | 9.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
3.0 | 27.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
3.0 | 9.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
3.0 | 6.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
3.0 | 9.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
3.0 | 38.6 | GO:0019825 | oxygen binding(GO:0019825) |
3.0 | 5.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.9 | 8.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
2.9 | 8.8 | GO:1990188 | euchromatin binding(GO:1990188) |
2.9 | 73.0 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
2.9 | 17.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
2.9 | 11.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
2.9 | 5.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
2.9 | 20.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
2.9 | 5.7 | GO:0051870 | methotrexate binding(GO:0051870) |
2.9 | 308.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
2.9 | 11.4 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
2.9 | 8.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
2.8 | 8.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
2.8 | 8.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
2.8 | 8.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
2.8 | 14.0 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
2.8 | 19.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
2.8 | 14.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
2.8 | 5.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
2.8 | 5.6 | GO:1990715 | mRNA CDS binding(GO:1990715) |
2.8 | 8.4 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
2.8 | 8.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
2.8 | 22.2 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
2.8 | 16.6 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
2.7 | 22.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
2.7 | 24.7 | GO:0047485 | protein N-terminus binding(GO:0047485) |
2.7 | 35.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
2.7 | 13.7 | GO:0003680 | AT DNA binding(GO:0003680) |
2.7 | 13.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
2.7 | 189.2 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
2.7 | 32.3 | GO:0015643 | toxic substance binding(GO:0015643) |
2.7 | 10.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
2.7 | 8.0 | GO:1990460 | leptin receptor binding(GO:1990460) |
2.7 | 2.7 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
2.7 | 34.7 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
2.7 | 32.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
2.7 | 8.0 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
2.6 | 10.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
2.6 | 28.8 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
2.6 | 81.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
2.6 | 39.1 | GO:0017069 | snRNA binding(GO:0017069) |
2.6 | 23.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.6 | 7.8 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
2.6 | 5.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
2.6 | 36.1 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
2.6 | 28.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
2.6 | 2.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
2.6 | 7.7 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
2.5 | 53.5 | GO:0032947 | protein complex scaffold(GO:0032947) |
2.5 | 10.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
2.5 | 50.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
2.5 | 27.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
2.5 | 7.6 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
2.5 | 7.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
2.5 | 2.5 | GO:0019199 | transmembrane receptor protein kinase activity(GO:0019199) |
2.5 | 12.5 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
2.5 | 19.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
2.5 | 32.0 | GO:0005521 | lamin binding(GO:0005521) |
2.5 | 2.5 | GO:0015927 | trehalase activity(GO:0015927) |
2.5 | 110.3 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
2.4 | 12.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
2.4 | 26.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
2.4 | 43.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
2.4 | 4.8 | GO:0050780 | dopamine receptor binding(GO:0050780) |
2.4 | 14.4 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
2.4 | 2.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
2.4 | 33.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
2.4 | 52.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
2.4 | 14.3 | GO:0002054 | nucleobase binding(GO:0002054) |
2.4 | 4.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
2.4 | 7.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
2.4 | 11.8 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
2.3 | 2.3 | GO:0070538 | oleic acid binding(GO:0070538) |
2.3 | 23.4 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
2.3 | 32.8 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
2.3 | 4.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
2.3 | 2.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
2.3 | 6.9 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
2.3 | 6.9 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
2.3 | 23.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
2.3 | 29.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
2.3 | 9.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
2.3 | 87.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
2.3 | 6.9 | GO:0030492 | hemoglobin binding(GO:0030492) |
2.3 | 13.8 | GO:0070513 | death domain binding(GO:0070513) |
2.3 | 2.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
2.3 | 2.3 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
2.3 | 18.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
2.3 | 16.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
2.3 | 27.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
2.3 | 20.5 | GO:0048038 | quinone binding(GO:0048038) |
2.3 | 29.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
2.3 | 18.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
2.3 | 15.9 | GO:0018630 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
2.3 | 11.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
2.3 | 40.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
2.3 | 15.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
2.3 | 65.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
2.2 | 11.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
2.2 | 67.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
2.2 | 11.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
2.2 | 60.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
2.2 | 87.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
2.2 | 46.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
2.2 | 11.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
2.2 | 4.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
2.2 | 6.7 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
2.2 | 11.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
2.2 | 6.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
2.2 | 4.4 | GO:0030911 | TPR domain binding(GO:0030911) |
2.2 | 35.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
2.2 | 8.8 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
2.2 | 8.8 | GO:0035197 | siRNA binding(GO:0035197) |
2.2 | 2.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
2.2 | 15.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
2.2 | 8.7 | GO:0016151 | nickel cation binding(GO:0016151) |
2.2 | 2.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
2.2 | 4.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.2 | 45.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
2.2 | 64.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
2.2 | 4.3 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
2.1 | 25.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
2.1 | 6.4 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
2.1 | 102.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
2.1 | 6.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
2.1 | 8.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
2.1 | 2.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
2.1 | 8.5 | GO:0015368 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
2.1 | 14.9 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
2.1 | 17.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
2.1 | 8.5 | GO:0016972 | thiol oxidase activity(GO:0016972) |
2.1 | 8.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
2.1 | 8.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
2.1 | 6.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
2.1 | 10.6 | GO:0034046 | poly(G) binding(GO:0034046) |
2.1 | 18.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
2.1 | 10.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
2.1 | 6.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
2.1 | 2.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
2.1 | 8.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
2.1 | 48.0 | GO:0001047 | core promoter binding(GO:0001047) |
2.1 | 16.7 | GO:0003785 | actin monomer binding(GO:0003785) |
2.1 | 20.8 | GO:0035173 | histone kinase activity(GO:0035173) |
2.1 | 20.7 | GO:0019841 | retinol binding(GO:0019841) |
2.1 | 4.1 | GO:0004096 | catalase activity(GO:0004096) |
2.1 | 12.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
2.1 | 2.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
2.0 | 6.1 | GO:0015288 | porin activity(GO:0015288) |
2.0 | 2.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
2.0 | 4.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
2.0 | 6.1 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
2.0 | 18.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
2.0 | 10.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
2.0 | 135.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
2.0 | 12.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
2.0 | 10.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
2.0 | 8.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
2.0 | 2.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
2.0 | 102.0 | GO:0035326 | enhancer binding(GO:0035326) |
2.0 | 56.0 | GO:0015485 | cholesterol binding(GO:0015485) |
2.0 | 2.0 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
2.0 | 4.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
2.0 | 53.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
2.0 | 6.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
2.0 | 23.8 | GO:0031005 | filamin binding(GO:0031005) |
2.0 | 11.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
2.0 | 2.0 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
2.0 | 13.8 | GO:0032183 | SUMO binding(GO:0032183) |
2.0 | 5.9 | GO:0015265 | urea channel activity(GO:0015265) |
2.0 | 3.9 | GO:0002046 | opsin binding(GO:0002046) |
2.0 | 7.8 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
2.0 | 5.9 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.9 | 3.9 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
1.9 | 3.9 | GO:0048495 | Roundabout binding(GO:0048495) |
1.9 | 25.2 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
1.9 | 5.8 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
1.9 | 17.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
1.9 | 1.9 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
1.9 | 17.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.9 | 61.6 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
1.9 | 7.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
1.9 | 3.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.9 | 5.8 | GO:0051380 | norepinephrine binding(GO:0051380) |
1.9 | 28.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.9 | 11.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.9 | 9.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.9 | 7.6 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.9 | 9.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.9 | 132.6 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
1.9 | 1.9 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
1.9 | 69.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
1.9 | 7.5 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
1.9 | 1.9 | GO:0035198 | miRNA binding(GO:0035198) |
1.9 | 3.8 | GO:0070052 | collagen V binding(GO:0070052) |
1.9 | 11.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.9 | 9.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
1.9 | 5.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.9 | 5.6 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
1.9 | 5.6 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.9 | 22.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
1.9 | 14.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.9 | 3.7 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
1.9 | 1.9 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
1.9 | 20.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.8 | 5.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.8 | 46.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
1.8 | 3.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
1.8 | 1.8 | GO:0019966 | interleukin-1 binding(GO:0019966) |
1.8 | 38.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
1.8 | 47.3 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
1.8 | 1.8 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
1.8 | 48.9 | GO:0070330 | aromatase activity(GO:0070330) |
1.8 | 1.8 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
1.8 | 18.0 | GO:0001618 | virus receptor activity(GO:0001618) |
1.8 | 18.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.8 | 1.8 | GO:2001069 | glycogen binding(GO:2001069) |
1.8 | 7.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.8 | 53.5 | GO:0097110 | scaffold protein binding(GO:0097110) |
1.8 | 8.9 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
1.8 | 35.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.8 | 8.9 | GO:0005499 | vitamin D binding(GO:0005499) |
1.8 | 7.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
1.8 | 21.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.8 | 21.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
1.8 | 37.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
1.8 | 14.1 | GO:0010181 | FMN binding(GO:0010181) |
1.8 | 1.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.8 | 10.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.8 | 22.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
1.7 | 26.1 | GO:0046332 | SMAD binding(GO:0046332) |
1.7 | 5.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
1.7 | 3.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.7 | 5.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
1.7 | 19.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
1.7 | 32.8 | GO:0031369 | translation initiation factor binding(GO:0031369) |
1.7 | 3.5 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
1.7 | 5.2 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
1.7 | 3.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
1.7 | 3.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.7 | 3.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.7 | 13.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
1.7 | 1.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.7 | 10.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
1.7 | 3.4 | GO:0035473 | lipase binding(GO:0035473) |
1.7 | 1.7 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
1.7 | 1.7 | GO:0070061 | fructose binding(GO:0070061) |
1.7 | 1.7 | GO:0050692 | DBD domain binding(GO:0050692) |
1.7 | 163.4 | GO:0019902 | phosphatase binding(GO:0019902) |
1.7 | 18.5 | GO:0070628 | proteasome binding(GO:0070628) |
1.7 | 88.9 | GO:0042393 | histone binding(GO:0042393) |
1.7 | 8.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
1.7 | 65.2 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
1.7 | 8.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.7 | 1294.6 | GO:0008270 | zinc ion binding(GO:0008270) |
1.7 | 5.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.7 | 6.7 | GO:0008199 | ferric iron binding(GO:0008199) |
1.7 | 8.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
1.7 | 46.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
1.7 | 451.1 | GO:0019900 | kinase binding(GO:0019900) |
1.7 | 46.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
1.7 | 3.3 | GO:0019767 | IgE receptor activity(GO:0019767) |
1.6 | 19.6 | GO:0005112 | Notch binding(GO:0005112) |
1.6 | 124.0 | GO:0001948 | glycoprotein binding(GO:0001948) |
1.6 | 24.5 | GO:0050661 | NADP binding(GO:0050661) |
1.6 | 35.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.6 | 11.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
1.6 | 3.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.6 | 1.6 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
1.6 | 14.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
1.6 | 9.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.6 | 6.4 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
1.6 | 3.2 | GO:0030695 | GTPase regulator activity(GO:0030695) |
1.6 | 6.4 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
1.6 | 60.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
1.6 | 115.8 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
1.6 | 3.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.6 | 18.9 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
1.6 | 11.0 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
1.6 | 1.6 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
1.6 | 3.1 | GO:0051373 | FATZ binding(GO:0051373) |
1.6 | 6.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
1.6 | 3.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.6 | 17.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
1.6 | 3.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.6 | 3.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
1.6 | 7.8 | GO:1990446 | U1 snRNP binding(GO:1990446) |
1.5 | 7.7 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
1.5 | 6.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.5 | 4.6 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.5 | 10.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.5 | 6.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.5 | 30.6 | GO:0030507 | spectrin binding(GO:0030507) |
1.5 | 9.1 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
1.5 | 10.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
1.5 | 4.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
1.5 | 12.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.5 | 1.5 | GO:0050543 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
1.5 | 1.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.5 | 13.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
1.5 | 3.0 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.5 | 16.5 | GO:0008143 | poly(A) binding(GO:0008143) |
1.5 | 6.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.5 | 1.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
1.5 | 6.0 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.5 | 1.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
1.5 | 7.4 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
1.5 | 13.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
1.5 | 7.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.5 | 7.3 | GO:0044548 | S100 protein binding(GO:0044548) |
1.5 | 2.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.5 | 1.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.5 | 4.4 | GO:0031419 | cobalamin binding(GO:0031419) |
1.4 | 4.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
1.4 | 8.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.4 | 4.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.4 | 5.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.4 | 8.6 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
1.4 | 8.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.4 | 2.9 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
1.4 | 2.9 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
1.4 | 2.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.4 | 18.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.4 | 4.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.4 | 2.8 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
1.4 | 18.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
1.4 | 34.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
1.4 | 15.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
1.4 | 67.5 | GO:0005178 | integrin binding(GO:0005178) |
1.4 | 4.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
1.4 | 15.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
1.4 | 4.1 | GO:0071949 | FAD binding(GO:0071949) |
1.4 | 1.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.4 | 213.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
1.3 | 8.1 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.3 | 2.7 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
1.3 | 237.0 | GO:0008134 | transcription factor binding(GO:0008134) |
1.3 | 10.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
1.3 | 12.1 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
1.3 | 14.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
1.3 | 5.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.3 | 51.9 | GO:0038024 | cargo receptor activity(GO:0038024) |
1.3 | 2.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.3 | 18.6 | GO:0031072 | heat shock protein binding(GO:0031072) |
1.3 | 4.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.3 | 5.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.3 | 1.3 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) alpha1-adrenergic receptor activity(GO:0004937) |
1.3 | 2.6 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
1.3 | 2.6 | GO:0022829 | wide pore channel activity(GO:0022829) |
1.3 | 2.6 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.3 | 6.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
1.3 | 1.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.3 | 3.9 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
1.3 | 34.8 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
1.3 | 2.6 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
1.3 | 3.9 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
1.3 | 7.7 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
1.3 | 5.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
1.3 | 2.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
1.3 | 1.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
1.3 | 5.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
1.3 | 5.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
1.3 | 8.9 | GO:0003796 | lysozyme activity(GO:0003796) |
1.3 | 69.7 | GO:0008168 | methyltransferase activity(GO:0008168) |
1.3 | 8.9 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.3 | 3.8 | GO:0042834 | peptidoglycan binding(GO:0042834) |
1.3 | 1.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.3 | 3.8 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
1.3 | 5.0 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
1.2 | 3.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
1.2 | 2.5 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
1.2 | 3.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.2 | 60.5 | GO:0005506 | iron ion binding(GO:0005506) |
1.2 | 4.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.2 | 11.1 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
1.2 | 3.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
1.2 | 3.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.2 | 11.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
1.2 | 3.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
1.2 | 8.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.2 | 7.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
1.2 | 2.4 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) hexose transmembrane transporter activity(GO:0015149) |
1.2 | 3.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
1.2 | 3.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
1.2 | 1.2 | GO:0015250 | water channel activity(GO:0015250) |
1.2 | 1.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.2 | 7.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
1.2 | 6.0 | GO:0017040 | ceramidase activity(GO:0017040) |
1.2 | 3.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.2 | 32.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
1.2 | 90.0 | GO:0008201 | heparin binding(GO:0008201) |
1.2 | 10.8 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
1.2 | 12.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
1.2 | 2.4 | GO:0043121 | neurotrophin binding(GO:0043121) |
1.2 | 1.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.2 | 4.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
1.2 | 174.6 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
1.2 | 2.4 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.2 | 14.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
1.2 | 19.1 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
1.2 | 2.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
1.2 | 37.9 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
1.2 | 2.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.2 | 18.9 | GO:0005518 | collagen binding(GO:0005518) |
1.2 | 4.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
1.2 | 1.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.2 | 2.4 | GO:0036033 | mediator complex binding(GO:0036033) |
1.2 | 1.2 | GO:0032934 | sterol binding(GO:0032934) |
1.2 | 1.2 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
1.2 | 37.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
1.2 | 1.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.2 | 17.4 | GO:0004527 | exonuclease activity(GO:0004527) |
1.2 | 9.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
1.2 | 3.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.1 | 2.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
1.1 | 1.1 | GO:0050733 | RS domain binding(GO:0050733) |
1.1 | 1.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.1 | 3.4 | GO:0016015 | morphogen activity(GO:0016015) |
1.1 | 18.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
1.1 | 23.7 | GO:0004386 | helicase activity(GO:0004386) |
1.1 | 7.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.1 | 54.0 | GO:0003724 | RNA helicase activity(GO:0003724) |
1.1 | 5.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
1.1 | 4.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
1.1 | 6.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.1 | 10.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
1.1 | 4.5 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
1.1 | 18.8 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
1.1 | 1.1 | GO:0019002 | GMP binding(GO:0019002) |
1.1 | 629.4 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
1.1 | 3.3 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
1.1 | 2.2 | GO:0036122 | BMP binding(GO:0036122) |
1.1 | 9.9 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.1 | 2.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
1.1 | 5.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
1.1 | 5.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.1 | 3.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
1.1 | 116.5 | GO:0003924 | GTPase activity(GO:0003924) |
1.1 | 2.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
1.1 | 35.2 | GO:0003712 | transcription cofactor activity(GO:0003712) |
1.1 | 4.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.1 | 9.6 | GO:0015928 | fucosidase activity(GO:0015928) |
1.1 | 7.5 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
1.1 | 2.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.0 | 2.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.0 | 3.1 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.0 | 5.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.0 | 8.4 | GO:0016717 | acyl-CoA desaturase activity(GO:0016215) oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
1.0 | 22.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
1.0 | 2.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.0 | 16.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
1.0 | 4.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.0 | 8.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
1.0 | 120.6 | GO:0005525 | GTP binding(GO:0005525) |
1.0 | 2.0 | GO:1990459 | transferrin receptor binding(GO:1990459) |
1.0 | 10.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
1.0 | 3.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.0 | 6.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
1.0 | 5.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
1.0 | 2.0 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.0 | 14.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
1.0 | 1.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.0 | 1.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
1.0 | 1.0 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
1.0 | 2.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
1.0 | 11.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.0 | 2.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.0 | 8.7 | GO:0016502 | G-protein coupled nucleotide receptor activity(GO:0001608) purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
1.0 | 1.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
1.0 | 4.8 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.0 | 237.3 | GO:0001067 | regulatory region nucleic acid binding(GO:0001067) |
1.0 | 2.9 | GO:0030332 | cyclin binding(GO:0030332) |
1.0 | 3.8 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.0 | 1.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.0 | 26.6 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.9 | 40.8 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.9 | 4.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.9 | 35.0 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.9 | 64.2 | GO:0003774 | motor activity(GO:0003774) |
0.9 | 3.8 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.9 | 0.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.9 | 13.2 | GO:0001848 | complement binding(GO:0001848) |
0.9 | 2.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.9 | 17.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.9 | 1.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.9 | 17.4 | GO:0005507 | copper ion binding(GO:0005507) |
0.9 | 2.7 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.9 | 10.0 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.9 | 333.7 | GO:0003677 | DNA binding(GO:0003677) |
0.9 | 3.6 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.9 | 4.5 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.9 | 3.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.9 | 80.7 | GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides(GO:0016818) |
0.9 | 7.1 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.9 | 1.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.9 | 16.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.9 | 43.6 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.9 | 5.2 | GO:0034847 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.9 | 37.3 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.9 | 2.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.9 | 1.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.9 | 3.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.9 | 2.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.9 | 17.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.9 | 1.7 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.8 | 3.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.8 | 0.8 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.8 | 5.9 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.8 | 1.7 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.8 | 2.5 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.8 | 3.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.8 | 5.0 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.8 | 6.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.8 | 2.5 | GO:0017022 | myosin binding(GO:0017022) |
0.8 | 42.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.8 | 22.6 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.8 | 2.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.8 | 0.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.8 | 3.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.8 | 2.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.8 | 5.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.8 | 0.8 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.8 | 0.8 | GO:0031013 | troponin I binding(GO:0031013) |
0.8 | 2.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.8 | 1.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.8 | 8.7 | GO:0042805 | actinin binding(GO:0042805) |
0.8 | 0.8 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.8 | 12.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.8 | 1.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.8 | 12.4 | GO:0004601 | peroxidase activity(GO:0004601) |
0.8 | 7.0 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.8 | 1.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.8 | 2.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.8 | 15.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.8 | 3.8 | GO:0045502 | dynein binding(GO:0045502) |
0.7 | 4.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.7 | 0.7 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.7 | 4.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.7 | 1.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.7 | 3.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.7 | 67.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.7 | 8.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.7 | 0.7 | GO:0031489 | myosin V binding(GO:0031489) |
0.7 | 5.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.7 | 2.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.7 | 2.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.7 | 1.5 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.7 | 10.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.7 | 5.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.7 | 0.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.7 | 3.6 | GO:0000049 | tRNA binding(GO:0000049) |
0.7 | 15.0 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.7 | 7.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.7 | 0.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.7 | 1.4 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.7 | 1.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.7 | 0.7 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.7 | 2.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.7 | 1.4 | GO:0031432 | titin binding(GO:0031432) |
0.7 | 0.7 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.7 | 0.7 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.7 | 15.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.7 | 6.9 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.7 | 0.7 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.7 | 2.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.7 | 8.2 | GO:0008748 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) NADPH:sulfur oxidoreductase activity(GO:0043914) epoxyqueuosine reductase activity(GO:0052693) |
0.7 | 2.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.7 | 7.5 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.7 | 31.2 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.7 | 2.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.7 | 1.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.7 | 13.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.7 | 4.7 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.7 | 15.9 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.7 | 0.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.7 | 7.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.7 | 14.4 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.6 | 9.1 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.6 | 10.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.6 | 5.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.6 | 1.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.6 | 0.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.6 | 1.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.6 | 3.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.6 | 56.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.6 | 3.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.6 | 27.6 | GO:0051015 | actin filament binding(GO:0051015) |
0.6 | 1.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.6 | 0.6 | GO:0042887 | amide transmembrane transporter activity(GO:0042887) |
0.6 | 0.6 | GO:0019961 | interferon binding(GO:0019961) |
0.6 | 15.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.6 | 1.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.6 | 11.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.6 | 1.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.6 | 2.4 | GO:0016209 | antioxidant activity(GO:0016209) |
0.6 | 0.6 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.6 | 21.2 | GO:0015293 | symporter activity(GO:0015293) |
0.6 | 21.7 | GO:0044325 | ion channel binding(GO:0044325) |
0.6 | 1.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.6 | 13.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.6 | 0.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.6 | 4.1 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.6 | 0.6 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.6 | 0.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.6 | 2.3 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.6 | 1.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.6 | 1.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.6 | 6.3 | GO:0017016 | Ras GTPase binding(GO:0017016) |
0.6 | 1.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.6 | 5.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.6 | 0.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.6 | 2.3 | GO:0016595 | glutamate binding(GO:0016595) |
0.6 | 0.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.6 | 22.7 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.6 | 5.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.6 | 1.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.6 | 83.4 | GO:0019904 | protein domain specific binding(GO:0019904) |
0.6 | 1.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.6 | 11.7 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.6 | 6.1 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.6 | 18.3 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.6 | 85.8 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.6 | 4.4 | GO:0051117 | ATPase binding(GO:0051117) |
0.6 | 1.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.6 | 6.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.6 | 1.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.5 | 2.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.5 | 6.0 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.5 | 2.7 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.5 | 2.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.5 | 1.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.5 | 1.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.5 | 2.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.5 | 2.6 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.5 | 1.0 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.5 | 59.4 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.5 | 7.3 | GO:0060090 | binding, bridging(GO:0060090) |
0.5 | 5.7 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.5 | 10.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.5 | 7.7 | GO:0048029 | monosaccharide binding(GO:0048029) |
0.5 | 2.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.5 | 1.0 | GO:0016594 | glycine binding(GO:0016594) |
0.5 | 1.0 | GO:0030546 | receptor activator activity(GO:0030546) |
0.5 | 0.5 | GO:0048185 | activin binding(GO:0048185) |
0.5 | 1.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.5 | 2.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.5 | 0.5 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.5 | 4.5 | GO:0043621 | protein self-association(GO:0043621) |
0.5 | 1.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.5 | 10.0 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.5 | 0.5 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.5 | 0.5 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.5 | 1.5 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.5 | 14.8 | GO:0016301 | kinase activity(GO:0016301) |
0.5 | 2.0 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.5 | 25.4 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.5 | 168.3 | GO:0000166 | nucleotide binding(GO:0000166) nucleoside phosphate binding(GO:1901265) |
0.5 | 1.0 | GO:0016874 | ligase activity(GO:0016874) |
0.5 | 1.0 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.5 | 8.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.5 | 0.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.5 | 0.5 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.5 | 0.5 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.5 | 1.8 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.5 | 1.4 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.5 | 8.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.5 | 19.6 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.5 | 0.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.4 | 61.4 | GO:0005198 | structural molecule activity(GO:0005198) |
0.4 | 1.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.4 | 0.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.4 | 1.3 | GO:0019842 | vitamin binding(GO:0019842) |
0.4 | 0.4 | GO:0009055 | electron carrier activity(GO:0009055) |
0.4 | 1.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.4 | 2.2 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.4 | 0.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.4 | 2.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.4 | 33.8 | GO:0008289 | lipid binding(GO:0008289) |
0.4 | 34.6 | GO:0030234 | enzyme regulator activity(GO:0030234) |
0.4 | 1.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 0.4 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.4 | 0.4 | GO:0031433 | telethonin binding(GO:0031433) |
0.4 | 0.4 | GO:0019864 | IgG binding(GO:0019864) |
0.4 | 1.7 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.4 | 0.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.4 | 0.8 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.4 | 13.6 | GO:0008565 | protein transporter activity(GO:0008565) |
0.4 | 3.7 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.4 | 0.4 | GO:0015926 | glucosidase activity(GO:0015926) |
0.4 | 0.4 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.4 | 0.8 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.4 | 4.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.4 | 0.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.4 | 0.8 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.4 | 90.0 | GO:0042802 | identical protein binding(GO:0042802) |
0.4 | 0.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.4 | 14.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.4 | 9.0 | GO:0070851 | growth factor receptor binding(GO:0070851) |
0.4 | 0.8 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.4 | 3.9 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.4 | 1.6 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.4 | 3.1 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.4 | 1.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.4 | 0.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.4 | 0.4 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.4 | 0.4 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.4 | 0.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.4 | 1.1 | GO:0050662 | coenzyme binding(GO:0050662) |
0.4 | 433.2 | GO:0005515 | protein binding(GO:0005515) |
0.4 | 4.4 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.4 | 10.8 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.4 | 3.9 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.4 | 0.7 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.4 | 0.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.4 | 1.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.3 | 2.8 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.3 | 0.7 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.3 | 5.8 | GO:0008083 | growth factor activity(GO:0008083) |
0.3 | 18.3 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.3 | 26.6 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.3 | 1.3 | GO:0042562 | hormone binding(GO:0042562) |
0.3 | 23.6 | GO:0005125 | cytokine activity(GO:0005125) |
0.3 | 3.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 119.4 | GO:0046872 | metal ion binding(GO:0046872) |
0.3 | 18.7 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.3 | 3.2 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.3 | 0.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 8.0 | GO:0008528 | G-protein coupled peptide receptor activity(GO:0008528) |
0.3 | 0.6 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.3 | 1.1 | GO:0020037 | heme binding(GO:0020037) |
0.3 | 0.8 | GO:0003823 | antigen binding(GO:0003823) |
0.3 | 2.0 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 0.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 2.3 | GO:0042277 | peptide binding(GO:0042277) |
0.2 | 0.2 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 0.2 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
0.2 | 20.3 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.2 | 3.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.2 | 38.0 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.2 | 0.3 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.2 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 0.2 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 140.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 0.3 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.1 | 0.1 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.1 | GO:0005231 | excitatory extracellular ligand-gated ion channel activity(GO:0005231) |
0.1 | 4.0 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.6 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.1 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 0.1 | GO:0036094 | small molecule binding(GO:0036094) |
0.0 | 0.0 | GO:0015232 | heme transporter activity(GO:0015232) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.5 | 13.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
4.8 | 76.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
4.7 | 37.5 | ST STAT3 PATHWAY | STAT3 Pathway |
4.4 | 127.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
4.2 | 12.5 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
4.0 | 56.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
3.8 | 65.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
3.7 | 95.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
3.7 | 33.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
3.7 | 51.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
3.6 | 91.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
3.6 | 17.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
3.5 | 67.4 | PID IGF1 PATHWAY | IGF1 pathway |
3.4 | 37.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
3.4 | 245.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
3.4 | 64.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
3.3 | 109.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
3.3 | 79.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
3.3 | 45.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
3.2 | 142.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
3.2 | 41.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
3.2 | 66.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
3.2 | 85.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
3.1 | 62.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
3.1 | 21.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
3.0 | 27.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
2.9 | 20.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
2.9 | 80.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
2.8 | 168.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
2.8 | 75.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
2.7 | 19.2 | PID IFNG PATHWAY | IFN-gamma pathway |
2.7 | 32.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
2.7 | 45.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
2.6 | 26.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
2.6 | 2.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
2.6 | 10.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
2.6 | 35.8 | ST GA13 PATHWAY | G alpha 13 Pathway |
2.5 | 58.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
2.5 | 25.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
2.5 | 32.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
2.5 | 40.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
2.5 | 34.4 | PID RHOA PATHWAY | RhoA signaling pathway |
2.5 | 24.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
2.5 | 34.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
2.4 | 97.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
2.4 | 67.8 | PID ARF6 PATHWAY | Arf6 signaling events |
2.4 | 33.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
2.4 | 72.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
2.4 | 14.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
2.4 | 23.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
2.4 | 195.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
2.4 | 49.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
2.3 | 55.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
2.3 | 32.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
2.3 | 23.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
2.3 | 27.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
2.3 | 105.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
2.3 | 16.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
2.3 | 77.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
2.1 | 50.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
2.1 | 51.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
2.0 | 27.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
2.0 | 23.4 | PID ALK1 PATHWAY | ALK1 signaling events |
1.9 | 3.9 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
1.9 | 30.2 | PID BARD1 PATHWAY | BARD1 signaling events |
1.8 | 20.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
1.8 | 3.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
1.8 | 56.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.7 | 27.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
1.7 | 41.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
1.6 | 3.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.6 | 4.9 | PID ALK2 PATHWAY | ALK2 signaling events |
1.6 | 4.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
1.6 | 4.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.6 | 16.0 | PID ARF 3PATHWAY | Arf1 pathway |
1.6 | 6.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.6 | 7.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
1.5 | 9.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.5 | 10.8 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
1.5 | 41.4 | PID E2F PATHWAY | E2F transcription factor network |
1.5 | 10.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
1.5 | 4.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.5 | 19.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
1.5 | 24.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
1.5 | 1.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.4 | 8.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.4 | 9.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
1.4 | 16.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
1.3 | 16.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.3 | 2.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.3 | 13.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
1.3 | 14.5 | PID FOXO PATHWAY | FoxO family signaling |
1.3 | 28.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
1.3 | 23.2 | PID LKB1 PATHWAY | LKB1 signaling events |
1.3 | 3.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.3 | 10.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
1.2 | 22.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
1.2 | 15.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.2 | 20.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.2 | 1.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.2 | 2.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
1.2 | 36.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
1.2 | 32.2 | PID PLK1 PATHWAY | PLK1 signaling events |
1.1 | 11.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.1 | 3.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
1.1 | 15.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
1.1 | 28.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
1.1 | 24.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
1.1 | 21.2 | PID P73PATHWAY | p73 transcription factor network |
1.1 | 14.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
1.1 | 4.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
1.1 | 8.5 | PID ATM PATHWAY | ATM pathway |
1.1 | 4.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.1 | 8.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.0 | 11.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.0 | 3.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
1.0 | 15.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
1.0 | 16.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
1.0 | 6.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.0 | 5.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
1.0 | 8.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.0 | 4.1 | PID EPO PATHWAY | EPO signaling pathway |
1.0 | 12.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
1.0 | 17.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
1.0 | 16.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
1.0 | 1.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.9 | 13.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.9 | 24.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.9 | 16.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.9 | 12.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.9 | 6.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.8 | 5.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.8 | 9.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.8 | 145.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.8 | 3.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.8 | 3.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.8 | 1.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.7 | 16.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.7 | 6.5 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.7 | 0.7 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.7 | 85.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.7 | 9.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.7 | 4.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.7 | 6.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.7 | 8.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.7 | 22.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.7 | 6.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.6 | 11.7 | PID BMP PATHWAY | BMP receptor signaling |
0.6 | 9.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.6 | 0.6 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.6 | 113.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.6 | 3.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.6 | 0.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.6 | 0.6 | PID SHP2 PATHWAY | SHP2 signaling |
0.6 | 75.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.6 | 1.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.6 | 18.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.6 | 2.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.6 | 4.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.6 | 7.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.6 | 1.7 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.6 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.5 | 1.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.5 | 5.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.5 | 1.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.5 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.5 | 2.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.5 | 1.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.5 | 1.9 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.5 | 0.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 0.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.4 | 2.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.4 | 7.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.4 | 3.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.4 | 1.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.4 | 0.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.4 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.4 | 1.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.4 | 0.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 1.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.3 | 2.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 1.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 0.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 1.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 5.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.3 | 5.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 0.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 1.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 0.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 0.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 0.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.6 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.6 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.2 | PID FGF PATHWAY | FGF signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.5 | 105.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
7.2 | 71.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
6.7 | 13.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
6.4 | 102.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
6.0 | 6.0 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
5.9 | 58.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
5.6 | 61.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
5.2 | 15.6 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
5.0 | 55.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
4.3 | 21.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
4.3 | 51.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
4.2 | 37.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
4.2 | 79.3 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
3.9 | 43.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
3.9 | 15.8 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
3.9 | 35.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
3.8 | 49.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
3.8 | 68.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
3.8 | 41.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
3.8 | 86.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
3.6 | 76.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
3.6 | 39.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
3.6 | 21.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
3.6 | 7.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
3.6 | 96.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
3.5 | 55.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
3.5 | 79.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
3.4 | 3.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
3.4 | 75.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
3.4 | 34.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
3.3 | 33.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
3.3 | 33.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
3.3 | 56.2 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
3.3 | 42.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
3.2 | 25.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
3.2 | 44.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
3.2 | 28.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
3.1 | 87.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
3.1 | 104.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
3.1 | 39.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
3.0 | 81.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
3.0 | 9.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
3.0 | 45.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
3.0 | 21.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
3.0 | 29.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
2.9 | 11.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
2.9 | 67.1 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
2.8 | 30.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
2.8 | 50.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
2.8 | 44.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
2.8 | 27.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
2.7 | 8.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
2.7 | 38.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
2.7 | 8.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
2.6 | 7.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
2.6 | 42.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
2.6 | 2.6 | REACTOME OPSINS | Genes involved in Opsins |
2.6 | 47.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
2.6 | 20.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
2.6 | 38.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
2.5 | 33.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
2.5 | 44.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
2.5 | 17.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
2.4 | 19.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
2.4 | 31.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
2.4 | 31.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
2.4 | 19.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
2.4 | 92.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
2.4 | 145.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
2.3 | 60.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
2.3 | 16.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
2.3 | 92.3 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
2.3 | 32.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
2.3 | 54.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
2.2 | 71.9 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
2.2 | 20.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
2.2 | 29.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
2.2 | 20.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
2.2 | 26.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
2.2 | 22.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
2.2 | 30.8 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
2.2 | 69.3 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
2.2 | 6.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
2.1 | 167.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
2.1 | 32.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
2.1 | 181.9 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
2.1 | 124.0 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
2.1 | 23.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
2.1 | 12.4 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
2.0 | 24.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
2.0 | 8.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
2.0 | 27.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
2.0 | 6.0 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
2.0 | 87.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.9 | 11.7 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
1.9 | 11.7 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
1.9 | 3.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
1.9 | 30.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.9 | 5.7 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
1.9 | 1.9 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
1.9 | 20.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.9 | 3.7 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.9 | 24.2 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
1.9 | 40.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
1.8 | 22.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
1.8 | 20.1 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
1.8 | 21.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
1.8 | 19.9 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.8 | 72.3 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
1.8 | 17.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.8 | 3.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.8 | 3.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
1.7 | 164.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.7 | 3.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.7 | 36.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
1.7 | 22.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
1.7 | 11.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
1.7 | 8.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
1.7 | 35.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
1.7 | 34.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
1.6 | 1.6 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
1.6 | 4.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.6 | 32.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.6 | 3.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.6 | 11.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.6 | 19.1 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
1.6 | 9.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.6 | 32.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.5 | 10.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.5 | 46.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.5 | 3.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.5 | 13.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.5 | 29.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
1.5 | 16.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
1.5 | 23.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.4 | 30.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
1.4 | 5.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
1.4 | 12.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.4 | 8.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.4 | 21.4 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
1.4 | 55.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
1.4 | 11.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.4 | 12.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.4 | 104.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.4 | 6.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.3 | 6.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.3 | 2.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
1.3 | 34.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
1.3 | 49.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
1.3 | 53.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
1.3 | 21.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
1.3 | 1.3 | REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | Genes involved in Assembly of the pre-replicative complex |
1.3 | 4.0 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
1.3 | 14.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
1.3 | 9.0 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
1.3 | 1.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.3 | 20.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
1.3 | 98.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
1.3 | 45.5 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
1.3 | 7.6 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
1.3 | 8.8 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
1.2 | 44.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
1.2 | 16.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.2 | 3.7 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
1.2 | 44.6 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
1.2 | 29.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
1.2 | 6.2 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
1.2 | 20.9 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
1.2 | 50.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
1.2 | 7.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
1.1 | 7.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.1 | 175.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
1.1 | 19.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
1.1 | 12.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.1 | 3.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.1 | 41.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
1.1 | 1.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
1.1 | 3.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
1.1 | 18.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.1 | 22.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
1.0 | 9.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
1.0 | 14.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
1.0 | 12.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
1.0 | 24.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
1.0 | 13.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.0 | 4.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.0 | 15.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
1.0 | 3.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.0 | 8.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.0 | 2.9 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
1.0 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
1.0 | 18.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
1.0 | 10.7 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.9 | 12.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.9 | 36.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.9 | 16.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.9 | 3.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.9 | 4.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.9 | 3.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.9 | 21.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.9 | 0.9 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.9 | 7.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.9 | 123.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.9 | 25.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.9 | 7.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.9 | 4.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.9 | 9.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.9 | 3.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.9 | 8.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.8 | 1.7 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.8 | 3.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.8 | 1.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.8 | 9.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.8 | 3.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.8 | 15.1 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.8 | 7.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.8 | 3.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.8 | 3.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.8 | 5.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.8 | 5.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.8 | 8.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.8 | 13.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.8 | 0.8 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
0.8 | 3.8 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.7 | 43.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.7 | 1.5 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.7 | 2.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.7 | 2.9 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.7 | 1.4 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.7 | 12.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.7 | 1.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.7 | 18.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.7 | 10.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.6 | 1.9 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.6 | 2.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.6 | 3.7 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.6 | 5.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.6 | 33.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.6 | 33.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.6 | 0.6 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.6 | 8.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.6 | 1.8 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.6 | 1.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.6 | 0.6 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.6 | 28.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.5 | 13.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.5 | 15.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.5 | 10.3 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.5 | 3.6 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.5 | 5.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.5 | 5.3 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.5 | 2.8 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.5 | 6.4 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.5 | 6.4 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.5 | 1.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 1.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.5 | 1.8 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.4 | 0.4 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.4 | 3.6 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
0.4 | 1.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.4 | 2.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.4 | 2.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.4 | 8.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 1.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 0.3 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.3 | 2.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.3 | 1.0 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.3 | 2.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.3 | 7.8 | REACTOME TRANSLATION | Genes involved in Translation |
0.3 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 0.9 | REACTOME DEFENSINS | Genes involved in Defensins |
0.3 | 3.7 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.3 | 2.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.3 | 3.1 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.3 | 2.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 1.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 2.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 4.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 5.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 1.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.3 | 0.5 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.3 | 2.0 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.2 | 3.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 0.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.2 | 2.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 1.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 0.2 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.2 | 11.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 0.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 4.0 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.2 | 2.9 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.2 | 0.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 0.9 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 0.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 3.8 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.1 | 0.4 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 1.2 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |